touchPODCAST: Recent Episodes
touchpodcast
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.
Educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss how biomarker-driven insights and emerging therapies are shaping treatment decisions in PDAC. They cover early testing strategies, novel targeted and immunologic therapies, and evidence-based treatment sequencing across the disease continuum.
The experts:
- Dr. Allyson Ocean - Weill Cornell Medicine, New York, NY, USA
- Prof. Thierry Conroy - Institut de Cancérologie de Lorraine, University of Lorraine Nancy, France
- Dr. Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Revolution Medicines.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to three leading experts discussing the recent advances in timely, biomarker-guided diagnosis and how current and emerging intravenous and subcutaneous disease-modifying therapies may impact clinical practice in the future and enable treatment personalization based on the underlying pathology of Alzheimer’s disease
The experts
- Dr Soo Borson, Keck USC School of Medicine, Los Angeles, CA, USA
- Dr Clifford Singer, Northern Light Acadia Hospital, Bangor, ME, USA
- Dr Frederick Ketchum, University of Wisconsin-Madison, Madison, WI, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Eisai Inc.
Jointly provided by Partners for Advancing Clinical Education and touchIME in collaboration with the Gerontological Society of America (GSA).
For further information, visit:
www.touchNEUROLOGY.com
touchIN CONVERSATION for touchOPHTHALMOLOGY
As treatment options for geographic atrophy continue to evolve, clinicians face new opportunities and challenges in diagnosis, treatment planning, and patient engagement. Join retina specialists Dr. Samuel Minaker and Dr. Priya Vakharia for a peer-to-peer discussion on geographic atrophy care, covering the patient journey from diagnosis to effective patient management and communication.
The experts
- Dr. Samuel Minaker, Tyler Retina Consultants, Tyler, TX, USA
- Dr. Priya Vakharia, Retina Vitreous Associates of Florida, Tampa, FL, USA
This touchPODCAST is for HCPs in the USA only.
This activity is supported by an independent medical education grant from Apellis, a Subsidiary of Biogen.
Jointly provided by Partners for Advancing Clinical Education and touchIME.
For further information visit our website: www.touchOPHTHALMOLOGY.com
touchEXPERT FOCUS for touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY
Listen to a series of interviews with Dr. Toru Kubo as he shares his expert insights into real-world diagnostic pitfalls in cardiac amyloid light-chain amyloidosis (AL), stepwise application of the Japanese Circulation Society (JCS) diagnostic algorithm to achieve an accurate diagnosis of cardiac AL, and timely engagement of hematology and multidisciplinary discussion around transthyretin (TTR) stabilizer initiation.
The expert:
- Dr. Toru Kubo, Kochi Medical School, Kochi University, Japan
This touchPODCAST is recorded in Japanese and is intended for HCPs in Japan.
This activity is supported by an independent educational grant from Alexion Pharma GmbH.
Jointly provided by Partners for Advancing Clinical Education and TouchIME.
For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY
touchTALKS for touchNEUROLOGY
Listen to an autoimmune neuromuscular disease expert review the unmet needs for patients with generalized myasthenia gravis and explain how emerging targeted therapies address underlying disease mechanisms to improve patient outcomes.
The expert
- Dr. Richard Nowak, Yale School of Medicine, New Haven, CT, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchneurologyime.org/targeted-therapies-in-gmg/
touchCASES for touchOPHTHALMOLOGY
Listen to two experts as they discuss three cases illustrating the art and science of presbyopia-correcting intraocular lens (IOL) selection, from preoperative planning to patient satisfaction. They examine key decision points from preoperative assessment and clinical workup to presbyopia-correcting IOL selection in routine and complex cases.
The experts:
- Dr. Dagny Zhu, Zhu Vision - Modern Laser & Cataract Eye Surgery, Orange, CA, USA
- Prof. Renato Ambrósio Jr., Federal University of the State of Rio de Janeiro, Brazil
This activity is for HCPs in the USA, Canada, and Latin America.
This activity is funded by an independent medical education grant from Alcon Vision, LLC.
The activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchOPHTHALMOLOGY.com
touchTALKS for touchENDOCRINOLOGY
Listen to Dr. Richard Auchus, as he describes how hypercortisolism can lead to hyperglycemia and hypertension, and discusses how to recognize, screen, and manage hypercortisolism in at-risk patient populations.
The expert
- Dr Richard J. Auchus, University of Michigan, Ann Arbor, MI, USA.
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Corcept Therapeutics Incorporated.
This activity is jointly provided by Partners for Advancing Clinical Education and touchIME.
For further information visit our website: www.touchENDOCRINOLOGY.com
touchIN CONVERSATION for touchONCOLOGY
Identifying patients at risk of treatment attrition is an important part of treatment decision-making, as these patients may miss opportunities to receive subsequent treatments that could improve survival and quality of life. Listen to breast cancer experts consider the impact of treatment attrition in metastatic breast cancer and review evidence supporting the earlier integration of antibody–drug conjugates in the treatment pathway.
The experts
- Prof. Fatima Cardoso, Centre Antoine Lacassagne and Advanced Breast Cance (ABC) Global Alliance, Nice, France
- Asst. Prof. Domen Ribnikar, Institute of Oncology Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK.
This activity is supported by an independent medical education grant from Daiichi Sankyo Europe GmbH/AstraZeneca.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
touchCASES for touchNEUROLOGY
Hear from two European experts as they discuss how to strengthen diagnostic confidence in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Through three patient cases, they address how to recognize and differentiate CIDP variants from other polyneuropathies and consider how key diagnostic criteria can be applied to reinforce diagnostic confidence.
The experts:
- Prof. Dr. Claudia Sommer, University of Würzburg, Würzburg, Germany
- Dr. Filip Eftimov, Amsterdam UMC, Amsterdam, The Netherlands
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
This touchPODCAST is for HCPs outside of the UK.
For further information, visit our website: www.touchNEUROLOGY.com
touchEXPERT FOCUS for touchENDOCRINOLOGY
Listen to a series of interviews with Dr. Eden Miller who will provide her expert insights into the recognition of typical and euglycemic diabetic ketoacidosis (DKA), the current and emerging ketone monitoring methods, including continuous ketone monitoring and the importance of optimizing patient and caregiver education to reduce preventable DKA events and hospitalizations.
The expert:
- Dr. Eden Miller, Diabetes and Obesity Care, Bend, OR, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchENDOCRINOLOGY.com
touchCASES for touchONCOLOGY
Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.
The experts:
- Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy
- Dr Ilaria Colombo, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
This activity is supported by an independent educational grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchONCOLOGY.com
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with a leading expert in cataract surgery. Dr Filomena Ribeiro shares insights on the latest advances in pre-operative assessment, AI-enhanced IOL power calculation and functional depth-of-field (DOFi)-based lens selection, as well as emerging IOL materials and technologies. She also provides practical guidance on patient communication strategies to support consistent, patient-centred refractive outcomes.
The expert:
- Dr Filomena Ribeiro, Hospital da Luz Lisboa, University of Lisbon and Catholic University of Portugal, Lisbon, Portugal
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Alcon Eye Care UK Limited.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchophthalmologyime.org/personalizing-cataract-surgery-from-pre-op-precision-to-functional-vision-outcomes/
touchCASES for touchNEUROLOGY
Listen to two US-based experts as they discuss how to improve diagnostic accuracy in the USA for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). They will discuss three patient cases to illustrate how to recognize and differentiate CIDP variants from other polyneuropathies, and apply key diagnostic criteria to help strengthen a diagnosis.
The experts:
- Dr Karissa Gable, Duke University, Durham, NC, USA
- Dr Jeffrey Allen, University of Minnesota, Minneapolis, MN, USA
This activity is funded by an independent medical education grant from Sanofi Genzyme.
This activity is jointly provided by USF Health and touchIME.
This activity is for HCPs in the USA only.
For further information, visit our website: https://touchneurologyime.org/cidp-diagnostics/
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to provide more durable vision protection.
The expert:
- Dr. Diana Do, Stanford University School of Medicine, Palo Alto, CA, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchOPHTHALMOLOGY.com
touchTALKS for touchONCOLOGY
Listen to Dr Teresa Alonso-Gordoa, as she evaluates the latest data on dual EZH2/AR inhibition in mCRPC and explores how emerging evidence could influence clinical decision-making in the future.
The expert
- Dr. Teresa Alonso-Gordoa - Hospital Universitario Ramón y Cajal, Madrid, Spain
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Pfizer.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with three leading experts discussing neural-targeted therapies for dry eye disease (DED). The faculty describe the neuronal control of tear secretion, explore the mechanisms of action and clinical findings with neuromodulatory/neurostimulatory therapies for DED, and discuss how to integrate these therapies into personalized treatment plans.
The experts:
- Dr Anat Galor – Bascom Palmer Eye Institute, Miami, USA
- Dr Christopher Starr – Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, USA
- Dr Marjan Farid – University of California Irvine Medical Center, Irvine, USA
This touchPODCAST is for healthcare professionals in the USA, Canada and Latin America
This activity is funded by an independent medical education grant from Alcon Vision LLC.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchophthalmologyime.org
touchEXPERT FOCUS for touchONCOLOGY and touchRESPIRATORY
Listen to a series of short interviews with leading experts on computational pathology in NSCLC. The faculty, an oncologist, an oncologist-researcher and a pathologist, discuss the clinical value of computational pathology in NSCLC, review emerging tools and share practical insights on how these approaches can be applied in routine patient management.
The experts:
- Prof. Marina Garassino, University of Chicago, IL, USA
- Prof. Jakob Nikolas Kather, Technical University, Dresden and University Hospital Dresden, Germany
- Prof. Fernando Lopez-Rios, Hospital Universitario 12 de Octubre, Madrid, Spain
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from AstraZeneca.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites:
touchONCOLOGY: https://touchoncologyime.org/computational-pathology-in-nsclc-from-biomarker-discovery-to-clinical-integration/
touchRESPIRATORY: https://touchrespiratoryime.org/computational-pathology-in-nsclc-from-biomarker-discovery-to-clinical-integration/
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the future of care for patients with pancreatic ductal adenocarcinoma, or PDAC. The faculty provide their insights on the current unmet needs, the evolving role of imaging, biomarker testing, and treatment strategies, and how these developments may impact clinical care.
The experts:
- Dr Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States
- Prof. Michel Ducreux - Gustave Roussy Cancer Center, Villejuif, France
- Dr Thomas Hope - University of California, San Francisco, CA, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Dr Maria-João Menéres who will provide her expert insights into the mechanisms of retinal ganglion cell (RGC) damage in both primary open-angle and secondary, steroid-induced glaucoma, and the importance of neuroprotection to mitigate the risk of glaucoma development or progression.
The expert:
- Dr Maria-João Menéres, ULS Santo António, Porto, Portugal
This touchPODCAST is for HCPs in Portugal only.
This activity is funded by an independent medical education grant from Alimera Sciences Europe Limited.The activity is provided by touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: www.touchOPHTHALMOLOGY.com
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen as Prof. Sumit (Sam) Garg shares expert clinical insights on how AI-supported biometric analysis can increase refractive accuracy and support confident presbyopia-correcting IOL selection, including which patient and ocular characteristics are most likely to benefit from AI-based tools. He also outlines practical strategies for structuring preoperative counselling to set realistic expectations and improve patient satisfaction through clear, effective communication.
The expert:
- Prof. Sumit (Sam) Garg, University of California, Irvine, CA, USA
This touchPODCAST is for HCPs outside of the UK.
This educational activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchophthalmology.org
touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY
Listen to leading experts discuss guideline-directed strategies for mutational analysis and monitoring response when treating patients with chronic-phase chronic myeloid leukaemia with approved tyrosine kinase inhibitors.
The experts
- Dr Jorge Cortes, Georgia Cancer Center, Augusta, GA, USA
- Dr Elias Jabbour, MD Anderson Cancer Center, Houston, TX, USA
- Dr Vivian Oehler, Fred Hutch Cancer Center, Seattle, WA, USA
This touchPODCAST is for HCPs in the USA only.This activity is funded by an independent medical education grant from Takeda Development Center Americas, Inc.
Jointly provided by Partners for Advancing Clinical Education and touchIME.
For further information, visit our websites:
www.touchHAEMATOLOGY.com
www.touchONCOLOGY.com
touchEXPERT FOCUS for touchENDOCRINOLOGY
Listen to a series of short interviews with paediatric endocrinologist Dr Ashley Shoemaker as she discusses the clinical manifestations and pathophysiology of Prader–Willi syndrome (PWS), with a focus on hyperphagia by exploring the spectrum across the lifespan of PWS and shares best practices for managing PWS-related hyperphagia within a multidisciplinary framework.
The expert:
- Dr Ashley Shoemaker, Vanderbilt University Medical Center, Nashville, TN, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Soleno Therapeutics.
The activity is jointly provided by Partners for Advancing Clinical Education (Partners) and touchIME.
For further information, visit our website: https://touchendocrinologyime.org/hyperphagia-pws-recognition-management/
touchPANEL DISCUSSION for touchONCOLOGY and touchRESPIRATORY
Listen to leading experts discuss the role of antibody–drug conjugates (ADCs) in NSCLC with brain metastases, including the latest clinical trial evidence, practical approaches to patient selection and treatment sequencing alongside local CNS therapies, and the evolving pipeline of investigational ADCs.
The expert(s)
- Dr Lyudmila Bazhenova, Moore’s Cancer Center, San Diego, CA, USA
- Dr Elvire Pons-Tostivint, Nantes Université, Centre Hospitalier Universitaire Nantes, France
- Dr Julia Rotow, Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs only outside of the UK.*This activity is funded by an independent medical education grant fromAstraZeneca.
This activity is jointly provided by USF Health and touchIME.*touchIME is an EBAC® accredited provider.
For further information visit our websites:
www.touchONCOLOGY.com
www.touchRESPIRATORY.com
touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY
Listen to a panel of leading experts as they explore the latest advances in PNH pathophysiology, diagnostic approaches and therapeutic strategies, including data from ASH 2025, with practical insights for contemporary clinical practice.
The experts:
- Prof. Bruno Fattizzo, Università degli Studi di Milano, Milan, Italy
- Dr Austin Kulasekararaj, King’s College Hospital NHS Foundation Trust, London, UK
- Dr Srikanth Nagalla, Miami Cancer Institute, Miami, FL, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Alexion Pharma GmbH.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchHAEMATOLOGY.com or www.touchONCOLOGY.com
touchCASES for touchNEUROLOGY, touchCARDIO, touchENDOCRINOLOGY and touchRESPIRATORY
Listen to two experts as they discuss three cases illustrating the heterogeneous, multisystem nature of late-onset Pompe disease (LOPD). They examine key decision points from recognizing early clinical clues and confirming diagnosis to optimizing enzyme replacement therapy (ERT), monitoring progression and coordinating multidisciplinary, patient-centred care.
The experts:
- Prof. John Vissing, University of Copenhagen, Copenhagen, Denmark
- Prof. Pascal Laforêt, Versailles-Saint Quentin University, Versailles, France
This activity is for HCPs outside of the USA.
This activity is supported by an independent educational grant from Amicus Therapeutics UK LTD.
touchIME is an EBAC® accredited provider.
For further information visit our websites:
touchNEUROLOGY - https://touchneurologyime.org/diagnosis-monitoring-management-lopd/
touchCARDIO - https://touchcardioime.org/diagnosis-monitoring-management-lopd/
touchENDOCRINOLOGY - https://touchendocrinologyime.org/diagnosis-monitoring-management-lopd/
touchRESPIRATORY - https://touchrespiratoryime.org/diagnosis-monitoring-management-lopd/
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Dr Rakesh Popat review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the International Multiple Society (IMS) and American Society of Hematology (ASH) 2025 congresses. Dr Popat is then joined by fellow experts Dr Paula Rodríguez-Otero and Dr Roberto Mina to discuss the implications of these data for current and future clinical practice.
Overview
- Data reviews with Dr Popat
- Expert panel discussions with Dr Popat, Dr Rodríguez-Otero and Dr Mina on the themes below
Clinical themes
- Approved BCMA-directed therapeutic approaches
- Practical application of BCMA-directed therapies
- Future of treating RRMM: Emerging BCMA-directed therapies and combinations
The internationally renowned multiple myeloma expert faculty
- Dr Rakesh Popat: London, UK
- Dr Paula Rodríguez-Otero: Pamplona, Spain
- Dr Roberto Mina: Atlanta, GA, USA
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms
In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients.
Course director
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
The clinical expert
Prof. Nicholas Girard, Institut Curie, Paris, France
Module 2: Bridging resistance gaps post–EGFR-TKI: Expanding NSCLC treatment beyond actionable targets
In this module, Professor Pasi Jänne and Dr. Helena Yu discuss the evolving management of EGFR-mutant NSCLC after EGFR-TKI progression. They address challenges of unexplained resistance, review combination and ADC treatment approaches, and highlight key factors such as patient selection, safety and emerging biomarkers
Course director
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
The clinical expert
Dr Helena Yu, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Module 3: Targeting resistance in EGFR-mutant NSCLC: The role of biomarkers
In this module, Professor Pasi Jänne and Professor Paul Hofman explore how precision medicine and molecular resistance mechanisms are shaping testing strategies. They discuss the role of biomarkers, evolving guideline recommendations and how clinicians can adapt testing approaches to align with new targeted therapies.
Course director
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
The clinical expert
Prof. Paul Hofman, University Côte d’Azur, Nice, France.
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from AstraZeneca Ltd.
This medical education is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/egfr-tki-resistance-strategies-nsclc/
https://touchrespiratoryime.org/egfr-tki-resistance-strategies-nsclc/
touchEXPERT FOCUS for touchONCOLOGY
Listen to insights from Dr Kathleen Moore on the pathophysiology and molecular features of low-grade serous ovarian cancer (LGSOC) and how it differs from other ovarian cancers. She also discusses evidence-based treatment options and sequencing, as well as practical considerations relating to administration and side-effect management.
The expert:
- Dr Kathleen Moore, OH Health Stephenson Cancer Center, Oklahoma City, OK, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Verastem, Inc.
The activity is jointly provided by Partners for Advancing Clinical Education and touchIME.
For further information visit our website: www.touchONCOLOGY.com
touchIN CONVERSATION for touchHAEMATOLOGY
The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (MF). Listen to expert haematologists consider the burden of cytopenias in patients with MF and discuss strategies to reduce transfusion dependence, improve splenomegaly and personalize treatment with JAK inhibitors.
The experts
- Prof. Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- Dr Laura Fox, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
This touchPODCAST is for HCPs outside of the USA.
This activity is supported by an independent medical education grant from GSK.
This activity is provided by touchIME in collaboration with our Education Partner Haematology Nurses & Healthcare Professionals Group (HNHCP).
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchHAEMATOLOGY.com
touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY
Listen to a series of short interviews with three leading experts who provide their insights into early-line management of chronic myeloid leukaemia and the impact on quality of life.
The experts:
- Dr Delphine Rea, Hôpital Saint-Louis, Paris, France
- Prof. Andreas Hochhaus, Jena University Hospital, Jena, Germany
- Prof. Etab Atallah, Medical College of Wisconsin, Milwaukee, WI, USA
This activity is for healthcare professionals outside of the USA and UK.
This independent medical education is supported by Novartis and is provided by touchIME.
For further information visit our website: www.touchHAEMATOLOGY.com or www.touchONCOLOGY.com
touchTALKS for touchONCOLOGY
Listen to Dr Christine Bestvina, as she evaluates the latest data on KRAS mutations in NSCLC and explores how emerging evidence for targeted therapies could influence clinical decision-making.
The expert
- Dr Christine Bestvina, University of Chicago, Chicago, IL, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Revolution Medicines.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with four leading experts as they discuss the role of HER2 as a targetable biomarker in BTC and GEA. They examine the present treatment landscape for HER2-positive BTC and GEA and evaluate clinical implications of recent approvals and advances in current and emerging HER2-targeting therapies for HER2-positive BTC and GEA.
The experts
- Prof. Thomas Seufferlein, Ulm University, Ulm, Germany
- Dr Elizabeth Smyth, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- Prof. Florian Lordick, University of Leipzig, Leipzig, Germany
- Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium
This touchPODCAST is for HCPs outside of the UK
This activity is supported by an independent educational grant from Jazz Pharmaceuticals.
Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchONCOLOGY.com
touchPANEL DISCUSSION for touchONCOLOGY and touchENDOCRINOLOGY
Listen to a panel of leading experts discuss the optimal management of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), with a focus on peptide receptor radionuclide therapy (PRRT). The faculty provide their insights on the current state of the art, the evolving role of PRRT in GEP-NET treatment, and recent data with existing and emerging PRRT agents. The faculty will also consider future developments in this field, including personalized approaches to PRRT, and how they might impact clinical care.
The experts:
- Prof. Thorvardur Halfdanarson, Mayo Clinic Rochester, MN, USA
- Prof. Rocio Garcia-Carbonero, Hospital Universitario 12 de Octubre, Madrid, Spain
- Prof. Nicola Fazio, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from ITM Isotope Technologies Munich SE.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites: www.touchONCOLOGY.com and www.touchENDOCRINOLOGY.com
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms
In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients.
Course director
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
The clinical expert
Prof. Nicholas Girard, Institut Curie, Paris, France
Module 2: Bridging resistance gaps post–EGFR-TKI: Expanding NSCLC treatment beyond actionable targets
In this module, Professor Pasi Jänne and Dr Helena Yu discuss the evolving management of EGFR-mutant NSCLC after EGFR-TKI progression. They address challenges of unexplained resistance, review combination and ADC treatment approaches, and highlight key factors such as patient selection, safety and emerging biomarkers
Course director
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
The clinical expert
Dr Helena Yu, Memorial Sloan Kettering Cancer Center, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from AstraZeneca Ltd.
This medical education is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/egfr-tki-resistance-strategies-nsclc/
https://touchrespiratoryime.org/egfr-tki-resistance-strategies-nsclc/
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with two medical retina specialists and a biomarker expert who will provide their insights into the pathophysiology of diabetic macular oedema (DMO), including the inflammatory mechanisms of disease and how they may impact treatment. The faculty will also consider the clinical utility of optical coherence tomography (OCT) imaging biomarkers and emerging evidence on the evolving role of corticosteroids in the management of DMO.
The experts:
- Prof. Stela Vujosevic, Medical Retina Unit, IRCCS MultiMedica and University of Milan, Milan, Italy
- Prof. Francesco Bandello, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy
- Prof. Laurent Kodjikian, University of Lyon and Croix-Rousse University Hospital, Lyon, France
This touchPODCAST is for HCPs outside of the UK and USA.
This activity is funded by an independent medical education grant from Alimera Sciences Europe Ltd.The activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchOPHTHALMOLOGY.com
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of experts in epilepsy as they discuss how to promptly and accurately diagnose and manage Lennox–Gastaut syndrome (LGS). Moderated by a leading European expert, this episode brings together faculty from the Gulf region and Japan, as they explore diagnostic approaches in their regions, before sharing their unique regional perspectives and real-world experience in caring for patients with LGS.
The experts
- Prof. Nicola Specchio: Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
- Dr Raidah Al-Baradie: King Fahad Specialist Hospital, Dammam, Saudi Arabia
- Dr Taoufik Alsaadi: American Center for Neurology, Abu Dhabi, Dubai, UAE
- Prof. Eiji Nakagawa: National Center of Neurology and Psychiatry, Tokyo, Japan
- Prof. Hideo Yamanouchi: Saitama Medical University, Saitama, Japan
Chapters
- The disease state of LGS (00:00–18:47)
- Managing patients with LGS in the Gulf (18:48–37:00)
- Managing patients with LGS in Japan (37:01–56:25)
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical educational grant from Jazz Pharmaceuticals.
Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit: touchneurologyime.org/diagnosis-treatment-lennox-gastaut-syndrome/
touchEXPERT FOCUS for touchCARDIO
Listen to short interviews with two expert cardiologists discussing the role of current and emerging therapeutic classes that aim to address the unmet needs of patients with hypertrophic cardiomyopathy. The faculty will review current therapeutic approaches for managing obstructive versus nonobstructive hypertrophic cardiomyopathy to highlight existing gaps in patient care. They will then discuss the latest data for emerging therapeutic classes and consider how they may address patients’ unmet needs in the future.
The experts
- Dr Martin Maron, Lahey Hospital & Medical Center, Burlington, MA, USA
- Dr Michelle Michels, Erasmus MC, Rotterdam, The Netherlands
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is supported by an independent medical educational grant from Cytokinetics, Inc.
Jointly provided by Partners for Advancing Clinical Education and touchIME.touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchcardio.com/
Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients.
Course director
Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA
The clinical expert
Prof. Nicholas Girard, Institut Curie, Paris, France
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from AstraZeneca Ltd.
This medical education is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
touchONCOLOGY: https://touchoncologyime.org/egfr-tki-resistance-strategies-nsclc/
touchRESPIRATORY: https://touchrespiratoryime.org/egfr-tki-resistance-strategies-nsclc/
touchEXPERT FOCUS for touchONCOLOGY
Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC.
The expert:
- Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: www.touchONCOLOGY.com
touchIN CONVERSATION for touchCARDIOLOGY and touchENDOCRINOLOGY
Listen to two experts as they discuss the diagnosis, treatment and how to support patients with FCS. They cover how to recognize key clinical signs and symptoms, strategies to help manage symptoms, reduce triglyceride levels and prevent complications. They also share key insights from their experience with novel targeted therapies for FCS.
The expert(s)
- Professor Antonio Gallo, Sorbonne University Hospital Pitié-Salpêtrière, Paris, France
- Dr Vikesh Singh, Johns Hopkins University School of Medicine, Baltimore, MD, USA
This touchPODCAST is for HCPs in the USA and Europe only.
This activity is funded by an independent medical education grant from Arrowhead Pharmaceuticals, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites: https://touchcardioime.org/fcs-unmasked/ and https://touchendocrinologyime.org/fcs-unmasked/
touchEXPERT FOCUS for touchHAEMATOLOGY
Prof. Lucia de Franceschi, a leading expert in sickle cell disease, examines the clinical manifestations and burden of the condition, reviews current and emerging treatments and offers guidance on comprehensive lifespan care that addresses complications, quality of life, and disparities, while highlighting the essential role of multidisciplinary support.
The experts
- Prof. Lucia de Franceschi, University of Verona, Italy
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals, Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchHAEMATOLOGY.com
touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY
Listen to a series of short expert interviews on timely diagnosis and individualized care for Fabry disease, using genetic and clinical insights. Our faculty discuss strategies to reduce diagnostic delays, identify clinically relevant genetic variants and tailor treatment based on each patient's genotype–phenotype correlations.
The experts
- Dr Raphael Schiffmann, Texas Christian University, Fort Worth, TX, USA
- Ms Dawn Laney, Emory Genetic Clinical Trials Center, Atlanta, GA, USA
- Dr Ozlem Goker-Alpan, Lysosomal Disorders Research and Treatment Center (LDRTC), Fairfax, VA, USA
This touchPODCAST is for HCPs outside of the UK.This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our websites:
www.touchENDOCRINOLOGY.com www.touchCARDIO.com and www.touchNEUROLOGY.com
touchCASES for touchONCOLOGY
Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). They will discuss the cases of three patients which will cover first-line and second-line treatments as well as key considerations for their treatment plans in their patients' cases.
The experts:
- Dr Nabil Saba, Winship Cancer Institute, Emory University, Atlanta, GA, USA
- Dr Victoria Villaflor, Chao Family Comprehensive Cancer Center, UCI Health, Orange, CA, USA
This activity is for HCPs in the USA only
This activity is funded by an independent medical education grant from Coherus Biosciences.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/treatment-selection-in-r-m-npc/
touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY
Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.
The experts
- Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
- Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands
- Dr Francesca Gay, University of Torino, Italy
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME.touchIME is an EBAC® accredited provider.
For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice.
The experts:
- Dr Ike K Ahmed, Prism Eye Institute, Toronto, ON, Canada; John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA
- Dr David F Chang, University of California, San Francisco, CA, USA; Altos Eye Physicians, Los Altos, CA, USA
- Dr Jennifer Loh, Loh Ophthalmology Associates, Miami, FL, USA
This touchPODCAST is for HCPs in the USA, Latin America and Canada only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/phacoemulsification-cataract-surgery/
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accurately and promptly diagnose the condition, and reviews supportive care strategies to maximize patients’ functional vision and improve their wellbeing.
The expert:
- Prof. Elias Traboulsi, Cleveland Clinic, Cleveland, OH, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchOPHTHALMOLOGY.com
touchTALKS for touchENDOCRINOLOGY
Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sherr also explores strategies for prevention and early intervention plus the advantages, drawbacks and recent developments in ketone monitoring.
The experts
- Prof. Jennifer Sherr, Yale School of Medicine, New Haven, CT, US
*This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.
This activity is jointly provided by USF Health and touchIME.*
touchIME is an EBAC® accredited provider.For further information visit our website:
www.touchENDOCRINOLOGY.com
touchCASES for touchRESPIRATORY and touchCARDIO
This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial diagnosis and risk stratification to treatment initiation and escalation.
The experts:
- Dr Athénaïs Boucly, University of Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
- Prof. Pilar Escribano Subìas, Complutense University of Madrid, Spain
This touchPODCAST is for HCPs outside the UK
This activity is provided by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider
For further information, visit our websites: www.touchRESPIRATORY.com and www.touchCARDIO.com
touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY
Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effective use.
The experts:
- Dr Eden Miller, Diabetes and Obesity Care, Bend, OR, USA
- Dr Ian J Neeland, Case Western Reserve University, and Harrington Heart and Vascular Institute, University Hospitals Cleveland, OH, USA
This activity is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.
This activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchCARDIO.com and www.touchENDOCRINOLOGY.com
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches.
The experts
- Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium
- Prof. Florian Lordick, University of Leipzig, Leipzig, Germany
This touchPODCAST is for HCPs outside of the UK
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchONCOLOGY.com
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies.
The experts
- Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France
- Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy
- Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.This activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: https://touchoncologyime.org/panel-icis-in-ec/
touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO
Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at improving patient outcomes.
The expert:
- Dr Chafic Karam, University of Pennsylvania, Philadelphia, PA, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our websites:
https://touchneurology.com/ and https://touchcardio.com/
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Moreau
- Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below
Clinical themes
- Approved BCMA-directed therapeutic approaches
- Practical application of BCMA-directed therapies
- Future of treating RRMM: Emerging BCMA-directed therapies and combinations
The internationally renowned multiple myeloma expert faculty
- Prof. Philippe Moreau: Nantes, France
- Prof. Hermann Einsele: Würzburg, Germany
- Dr Paola Neri: Calgary, AB, Canada
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
touchEXPERT FOCUS for touchDERMATOLOGY
Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.
The expert:
- Prof. Ilona Frieden, University of California, San Francisco, CA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc.This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA).For further information visit our website:
https://touchdermaime.org/
NEW touchCASES for touchINFECTIOUS DISEASES
Listen to Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation.
The experts:
- Prof. José Arribas, University Hospital La Paz, Madrid, Spain,
- Ms Harriet Langanke, GSSG, Cologne, Germany
This touchPODCAST is for HCPs outside of the UK
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchinfectiousdiseases.com
touchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.
The experts
- Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
- Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchoncologyime.org/
touchEXPERT FOCUS for touchRESPIRATORY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
- Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchrespiratoryime.org/
touchEXPERT FOCUS for touchONCOLOGY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
- Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchoncologyime.org/
touchFOCUS for touchRESPIRATORY
In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.
The expert:
- Dr Christine Bestvina - University of Chicago, Chicago, IL, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.This activity is jointly provided by USF Health and touchIME.For further information visit our website: touchrespiratory.com
touchFOCUS for touchONCOLOGY
In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.
The expert:
- Dr Christine Bestvina - University of Chicago, Chicago, IL, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.This activity is jointly provided by USF Health and touchIME.For further information visit our website: touchoncology.com
touchEXPERT FOCUS touchOPHTHALMOLOGY
Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted approaches shaping clinical management today.
The expert
- Dr Laura Periman, Periman Eye Institute, Seattle, WA, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Alcon Vision, LLC.
The activity is jointly provided by USF Health and touchIME.
For further information, visit our website: https://touchophthalmologyime.org/advances-in-dry-eye-disease/
touchIN CONVERSATION for touchOPHTHALMOLOGY
Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They explore the importance of early identification of GA and how this can be achieved, examine the potential impact of new and emerging therapies for GA, and highlight key practical considerations for monitoring treatment outcomes and evaluating effectiveness of therapy in clinical practice.
The experts
- Prof. Giuseppe Querques, IRCCS Hospital San Raffaele, Milan, Italy
- Dr Arshad M. Khanani, Sierra Eye Associates, Reno, NV, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Astellas Pharma Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchophthalmologyime.org/
touchEXPERT FOCUS for touchNEUROLOGY
Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale for targeting BTK inhibitors. He reviews emerging clinical data supporting the use of BTK inhibitors and discusses how they may fit into the evolving treatment landscape. In this context, Prof. Montalban also considers current guideline-recommended therapies for progressive MS and highlights key areas of remaining unmet treatment need.
The expert
Prof. Xavier Montalban, Centre d'Esclerosi Múltiple de Catalunya (Cemcat) and Vall d'Hebron University Hospital, Barcelona, Spain
This touchPODCAST is for HCPs outside of the UK only.
This activity is provided by an independent medical education grant from Sanofi.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchneurology.com/
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to two expert neurologists and a neurology nurse as they explore the role of neonatal Fc receptor (FcRn) inhibitors in improving the burden of disease in patients with generalized myasthenia gravis. The faculty will consider how the burden of disease and treatment in patients with generalized myasthenia gravis can be used to inform treatment decisions, the latest clinical data for FcRn inhibitors and the best practice strategies for using FcRn inhibitors in clinical practice.
The experts
- Prof. Michael Nicolle – Western University and London Health Sciences Centre, London, ON, Canada
- Dr Karissa Gable – Duke University, Durham, NC, USA
- Ms Missy Pittman – Duke University, Durham, NC, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from Argenx and UCB, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/reducing-burden-of-disease-in-gmg-exploring-the-role-of-fcrn-inhibitors/
Listen to key experts from a multidisciplinary team review and discusswhy and how to implement continuous glucose monitoring in T2D.
The multidisciplinary team
- Endocrinologist: Prof Tina Vilsbøll
- Primary Care Physician: Dr Gihane Zarifa
- Nurse specialist: Ms. Lori Berard
- Patient advocate: Mr. Ostap Soroka
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/
Listen to key experts from a multidisciplinary team review and discussevolving options for insulin therapy.
The multidisciplinary team
- Endocrinologist: Prof Tina Vilsbøll
- Primary Care Physician: Dr Gihane Zarifa
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/
Listen to key experts from a multidisciplinary team review and discussclinical inertia in T2D.
The multidisciplinary team
- Endocrinologist: Prof Tina Vilsbøll
- Primary Care Physician: Dr Gihane Zarifa
- Patient advocate: Mr. Ostap Soroka
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/
touchSYMPOSIUM for touchRESPIRATORY
Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France.
Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC.
Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation
Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC
Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection
Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A.
This touchPODCAST is for HCPs outside of the UK.This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: https://touchoncologyime.org/
touchSYMPOSIUM for touchONCOLOGY
Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France.
Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC.
Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation
Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC
Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection
Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A.
This touchPODCAST is for HCPs outside of the UK.This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.For further information visit our website: https://touchoncologyime.org/
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes.
The experts
- Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA
- Dr Christina Lampe, University of Giessen, Giessen, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit: touchneurologyime.org/
touchPANEL DISCUSSION for touchENDOCRINOLOGY
Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes.
The experts
- Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA
- Dr Christina Lampe, University of Giessen, Giessen, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit: touchendocrinologyime.org/
touchIN CONVERSATION for touchONCOLOGY
Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizing patient selection and management, and examine emerging data that may influence future treatment paradigms.
The experts
- Dr Alexandra Leary, Gustave Roussy Cancer Center, Villejuif, France
- Dr Juan Francisco Grau, Gustave Roussy Cancer Center, Villejuif, France
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients.
The experts
- Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany
- Prof. Jean-Jacques Kiladjian – Université Paris Cité and Saint-Louis Hospital, Paris, France
- Prof. Alessandro Vannucchi – University of Florence, Florence, Italy
This touchPODCAST is for HCPs outside of the UK and USA only.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchhaematologyime.org/
Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
- Clinical oncology pharmacy specialist: Dr Scott Edwards, Dr. H. Bliss Murphy Cancer Center, St. John’s, Newfoundland, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
- Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape for neovascular age-related macular degeneration and diabetic macular oedema, share his perspective on how newly available treatments are influencing the existing standard of care and provide guidance on how new therapies can be effectively integrated into clinical practice.
The expert
- Prof. Peter Kaiser, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA
This touchPODCAST is for HCPs outside of the USA and UK only.This activity is funded by an independent medical education grant from Bayer Consumer Care AG.The activity is provided by touchIME.touchIME is an EBAC® accredited provider.For further information visit our website:
https://touchophthalmologyime.org/adopting-emerging-therapies-for-retinal-diseases
touchCONGRESS for touchCARDIO
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, German
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
touchCONGRESS for touchENDOCRINOLOGY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
touchCONGRESS for touchNEUROLOGY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
touchCONGRESS for touchRESPIRATORY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
touchMDT for touchONCOLOGY
Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors.
The multidisciplinary team and patient advocate:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Patient Advocate – Mr Tony Collier
Tackle Prostate Cancer, London, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
touchMDT for touchONCOLOGY
Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen.
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Pathologist – Prof. Albrecht Stenzinger
University of Heidelberg, Heidelberg, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
touchMDT for touchONCOLOGY
MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC
Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC).
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
touchEXPERT OPINIONS for touchCARDIO
Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D).
The experts
- Dr Sue Pedersen, University of Calgary, Calgary, Canada
- Prof. Carel le Roux, University College Dublin, Dublin, Ireland
- Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA
This touchPODCAST is for healthcare professionals outside of the USA and UK.This activity is funded by an independent medical education grant from Novo Nordisk A/S.This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchCARDIO.com
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D).
The experts
- Dr Sue Pedersen, University of Calgary, Calgary, Canada
- Prof. Carel le Roux, University College Dublin, Dublin, Ireland
- Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA
This touchPODCAST is for healthcare professionals outside of the USA and UK.This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchENDOCRINOLOGY.com
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three experts in breast cancer as they provide insights into the current guideline recommendations for the use of targeted therapy in patients with HR+/HER2– early breast cancer, evaluate the latest data for CDK4/6 inhibitors in this patient population and consider how to maximize the potential of these agents through risk stratification and safety considerations.
The experts
- Prof. Carlos Barrios: Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil
- Prof. Dr. med. Peter Fasching: University Hospital Erlangen and Comprehensive Cancer Center, Erlangen-EMN, Germany
- Dr Sonia Pernas: Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain
This touchPODCAST is for healthcare professionals outside of the UK and the USA.
This activity is funded by an independent medical education grant from Novartis.
This activity is provided by touchIME.
For further information visit our website:
www.touchONCOLOGY.com
touchIN CONVERSATION for touchONCOLOGY
Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexual health as they address healthcare professionals' questions on HPV vaccination. They provide insights into the burden of HPV-related oncological and non-oncological diseases, appropriate vaccination schedules for specific patient groups, and strategies to improve vaccine uptake across various healthcare settings.
The experts
- Dr Barbara Moscicki, UCLA Health and University of California, Los Angeles, CA, USA
- Dr Marc Steben, HPV Global Action and Université de Montréal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/in-conversation-improving-hpv-vaccine-uptake/
touchIN CONVERSATION for touchINFECTIOUS DISEASES
Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexual health as they address healthcare professionals' questions on HPV vaccination. They provide insights into the burden of HPV-related oncological and non-oncological diseases, appropriate vaccination schedules for specific patient groups, and strategies to improve vaccine uptake across various healthcare settings.
The experts
- Dr Barbara Moscicki, UCLA Health and University of California, Los Angeles, CA, USA
- Dr Marc Steben, HPV Global Action and Université de Montréal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchinfectiousdiseasesime.org/in-conversation-improving-hpv-vaccine-uptake/
touchFOCUS for touchONCOLOGY
In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies.
The expert:
- Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Sanofi US. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
touchFOCUS for touchHAEMATOLOGY
In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies.
The expert:
- Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Sanofi US.This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchHAEMATOLOGY.com
touchCONGRESS for ONCOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
- Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
- Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic
This touchPODCAST is for HCPs outside of the USA and UK.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/
touchCONGRESS for touchHAEMATOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
- Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
- Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic
This touchPODCAST is for HCPs outside of the USA and UK.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/
touchEXPERT OPINIONS for touchONCOLOGY
Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes.
The experts
- Dr David S Hong, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Eileen M O’Reilly, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
- Dr Rebecca S Heist, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Revolution Medicines.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/mutations-and-personalized-cancer-care-targeting-the-future/
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
- Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
- Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
- Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
- Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
- Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
- Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#
touchFOCUS for touchRESPIRATORY
Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.
The expert
- Prof. Céline Mascaux, Strasbourg University, Strasbourg, France
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchrespiratory.org/ADCs-in-NSCLC
touchFOCUS for touchONCOLOGY
Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.
The expert
- Prof. Céline Mascaux, Strasbourg University, Strasbourg, France
This touchPODCAST is for HCPs only
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchoncology.org/ADCs-in-NSCLC
touchSYMPOSIUM for touchHAEMATOLOGY
Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA.
Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies.
- Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life
- Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies
- Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data
- Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic
This touchPODCAST is for HCPs in the USA.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncologyime.org
touchSYMPOSIUM for touchHAEMATOLOGY
Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA.
Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies.
- Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life
- Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies
- Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data
- Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic
This touchPODCAST is for HCPs in the USA.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchhaematologyime.org
touchEXPERT FOCUS for touchONCOLOGY
Listen to three experts provide insights into the optimal management of neurofibromatosis
type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs).
Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered.
The experts
- Dr AeRang Kim, Children's National Hospital, Washington, DC, USA
- Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA
- Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Springworks
Therapeutics, Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/expert-focus-management-of-nf1/
touchEXPERT FOCUS for touchNEUROLOGY
Listen to three experts provide insights into the optimal management of neurofibromatosis
type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs).
Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered.
The experts
- Dr AeRang Kim, Children's National Hospital, Washington, DC, USA
- Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA
- Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Springworks
Therapeutics, Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchneurologyime.org/expert-focus-management-of-nf1/
touchEXPERT OPINIONS for touchONCOLOGY
Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this treatment modality.
The experts
- Dr Laura Mertens, Netherlands Cancer Institute, Amsterdam, The Netherlands
- Prof. Thomas Powles, Barts Cancer Centre, London, UK
- Ms Lindsay Diamond, Icahn School of Medicine at Mount Sinai, New York, NY, USA
This touchPODCAST is for healthcare professionals outside of the UK only.This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchONCOLOGY.com
touchEXPERT OPINIONS for touchDERMATOLOGY
Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.
The experts
- Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
- Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Dr Teresa Amaral, Tübingen University, Tübingen, Germany
This touchPODCAST is for healthcare professionals outside of the UK only
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchdermaime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.
The experts
- Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
- Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Dr Teresa Amaral, Tübingen University, Tübingen, Germany
This touchPODCAST is for healthcare professionals outside of the UK only
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma
touchFOCUS for touchOPHTHALMOLOGY
Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology.
The expert
- Dr John Ladas, Maryland Eye Consultants & Surgeons, Silver Spring, MD, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. and Carl Zeiss Meditec, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchophthalmology.com/
touchFOCUS for touchDERMATOLOGY
Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a multidisciplinary team approach.The expert:
- Prof. Amy Paller - Northwestern University Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Chiesi USA Inc. This activity is jointly provided by USF Health and touchIME.For further information visit our website: touchDERMA.com
touchEXPERT OPINIONS for touchIMMUNOLOGY
Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis.
The expert
Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/Primary-biliary-cholangitis-therapeutic-landscape
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis.
The expert
Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/primary-biliary-cholangitis-therapeutic-landscape
touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchONCOLOGY.com
touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchONCOLOGY.com
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchRESPIRATORY.com
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchRESPIRATORY.com
touchMDT for touchRESPIRATORY
What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?
Listen to key experts Prof. Suresh Senan, Dr Lizza Hendriks and Dr Jacob Sands discuss the impact of ICIs on the real-world management of patients with LS-SCLC, including guidance on monitoring for and management of possible immune-related side effects.
The multidisciplinary team
Radiation oncologist – Prof. Suresh Senan
Amsterdam University Medical Center, Amsterdam, The Netherlands
Pulmonologist – Dr Lizza Hendriks,
Maastricht University Medical Center, Maastricht, The Netherlands
Medical oncologist – Dr Jacob Sands
Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchrespiratoryime.org/mdt-immune-checkpoint-inhibitors-in-ls-sclc/
touchMDT for touchRESPIRATORY
What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?
Listen to experts Dr Jacob Sands and Prof. Suresh Senan discuss the latest data for ICIs in LS-SCLC, including data released at key congresses in 2024, and share their clinical insights.
The multidisciplinary team
Medical oncologist – Dr Jacob Sands
Dana-Farber Cancer Institute, Boston, MA, USA
Radiation oncologist – Prof. Suresh Senan
Amsterdam University Medical Center, Amsterdam, The Netherlands
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchrespiratoryime.org/mdt-immune-checkpoint-inhibitors-in-ls-sclc/
touchMDT for touchRESPIRATORY
What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?
Listen to experts Dr Lizza Hendriks and Prof. Suresh Senan discuss the rationale for using ICIs in LS-SCLC, including relevant evidence from clinical trials in extended-stage SCLC and LS-SCLC, and review the novel and emerging late-phase ICIs for LS-SCLC.
The multidisciplinary team:
Pulmonologist – Dr Lizza Hendriks,
Maastricht University Medical Center, Maastricht, The Netherlands
Radiation oncologist – Prof. Suresh Senan
Amsterdam University Medical Center, Amsterdam, The Netherlands
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchrespiratoryime.org/mdt-immune-checkpoint-inhibitors-in-ls-sclc/
touchMDT for touchONCOLOGY
What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?
Listen to key experts Prof. Suresh Senan, Dr Lizza Hendriks and Dr Jacob Sands discuss the impact of ICIs on the real-world management of patients with LS-SCLC, including guidance on monitoring for and management of possible immune-related side effects.
The multidisciplinary team
Radiation oncologist – Prof. Suresh Senan
Amsterdam University Medical Center, Amsterdam, The Netherlands
Pulmonologist – Dr Lizza Hendriks,
Maastricht University Medical Center, Maastricht, The Netherlands
Medical oncologist – Dr Jacob Sands
Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/mdt-immune-checkpoint-inhibitors-in-ls-sclc/
touchMDT for touchONCOLOGY
What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?
Listen to experts Dr Jacob Sands and Prof. Suresh Senan discuss the latest data for ICIs in LS-SCLC, including data released at key congresses in 2024, and share their clinical insights.
The multidisciplinary team
Medical oncologist – Dr Jacob Sands
Dana-Farber Cancer Institute, Boston, MA, USA
Radiation oncologist – Prof. Suresh Senan
Amsterdam University Medical Center, Amsterdam, The Netherlands
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/mdt-immune-checkpoint-inhibitors-in-ls-sclc/
touchMDT for touchONCOLOGY
What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?
Listen to experts Dr Lizza Hendriks and Prof. Suresh Senan discuss the rationale for using ICIs in LS-SCLC, including relevant evidence from clinical trials in extended-stage SCLC and LS-SCLC, and review the novel and emerging late-phase ICIs for LS-SCLC.
The multidisciplinary team:
Pulmonologist – Dr Lizza Hendriks,
Maastricht University Medical Center, Maastricht, The Netherlands
Radiation oncologist – Prof. Suresh Senan
Amsterdam University Medical Center, Amsterdam, The Netherlands
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/mdt-immune-checkpoint-inhibitors-in-ls-sclc/
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES
In this activity, Prof. Antoni Torres, a leading expert in respiratory infections, discusses the burden of pneumococcal disease in vulnerable patient populations, the evolving landscape of Streptococcus pneumoniae subtypes and the role that next-generation vaccines can play in preventing severe pneumococcal infections.
The expert
- Prof. Antoni Torres, University of Barcelona, Spain
This touchPODCAST is for HCPs outside of the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website:
www.touchINFECTIOUS DISEASES.com
touchCONGRESS for touchONCOLOGY
Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first-and later-line settings. Prof. Rosti is then joined by fellow experts, Prof. Susanne Saussele and Dr Carla Boquimpani, to consider the implications of these data for current and future clinical practice.
Overview
- Data reviews with Prof. Rosti
- Expert panel discussions with Prof. Susanne Saussele and Dr Carla Boquimpani on the themes below
Clinical themes
- Approved and emerging TKIs for CML in the first-line setting
- Approved and emerging TKIs for CML in the second- and later-line settings
- Potential impact of emerging data on current and future clinical practice
The internationally renowned multiple myeloma expert faculty
- Prof. Gianantonio Rosti: Meldola, Italy
- Prof. Susanne Saussele: Mannheim, Germany
- Dr Carla Boquimpani: Rio de Janeiro, Brazil
This touchPODCAST is for HCPs globally with the exclusion of the USA, the UK and Japan.
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: TBC
touchCONGRESS for touchHAEMATOLOGY
Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first-and later-line settings. Prof. Rosti is then joined by fellow experts, Prof. Susanne Saussele and Dr Carla Boquimpani, to consider the implications of these data for current and future clinical practice.
Overview
- Data reviews with Prof. Rosti
- Expert panel discussions with Prof. Susanne Saussele and Dr Carla Boquimpani on the themes below
Clinical themes
- Approved and emerging TKIs for CML in the first-line setting
- Approved and emerging TKIs for CML in the second- and later-line settings
- Potential impact of emerging data on current and future clinical practice
The internationally renowned multiple myeloma expert faculty
- Prof. Gianantonio Rosti: Meldola, Italy
- Prof. Susanne Saussele: Mannheim, Germany
- Dr Carla Boquimpani: Rio de Janeiro, Brazil
This touchPODCAST is for HCPs globally with the exclusion of the USA, the UK and Japan.
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: TBC
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading experts discuss best practice in the management of agitation in Alzheimer’s dementia and the potential of new pharmacological approaches that target aspects of the underlying pathophysiology.
The experts
- Prof. Jeffrey Cummings, University of Nevada, Las Vegas, NV, USA
- Prof. Krista Lanctôt, University of Toronto, ON, Canada
- Prof. James Galvin, University of Miami, FL, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
For further information visit:
https://touchneurologyime.org/cme/curriculums/agitation-in-alzheimers-dementia/
touchIN CONVERSATION for touchCARDIO
Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment landscape.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
The experts
- Prof. Manreet Kanwar, Allegheny General Hospital, Pittsburgh, PA, USA
- Prof. Jean-Luc Vachiéry, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium
For further information visit our website:
www.touchCARDIO.com
touchIN CONVERSATION for touchRESPIRATORY
Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment landscape.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
The experts
- Prof. Manreet Kanwar, Allegheny General Hospital, Pittsburgh, PA, USA
- Prof. Jean-Luc Vachiéry, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium
For further information visit our website:
www.touchRESPIRATORY.com
touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchONCOLOGY.com
touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchONCOLOGY.com
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchRESPIRATORY.com
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchRESPIRATORY.com
touchFOCUS for touchONCOLOGY
Listen to Dr Jennifer Carlisle, an expert in lung cancer, as she answers a series of questions on the targeted perioperative treatment strategies and best practices for patients with resectable and unresectable early-stage EGFR-mutant NSCLC. She also discusses how the evolving treatment landscape impacts biomarker testing and the importance of multidisciplinary care for optimizing outcomes in these patients.
The expert
Dr Jennifer Carlisle, Winship Cancer Institute of Emory University, Atlanta, GA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchoncology.org/EGFR-mutant-treatment-options-early-NSCLC
touchCONGRESS for touchONCOLOGY
Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mateos,
- Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below
Clinical themes
- Approved indications for BCMA-targeting agents,
- New approaches to the use of existing BCMA-targeting agents,
- Emerging BCMA-targeting agents
The internationally renowned multiple myeloma expert faculty
- Prof. María-Victoria Mateos: Salamanca, Spain,
- Dr Rakesh Popat: London, UK,
- Prof. Evangelos Terpos: Athens, Greece
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/bcma-mm-comy-eha-2024
touchCONGRESS for touchHAEMATOLOGY
Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mateos,
- Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below
Clinical themes
- Approved indications for BCMA-targeting agents,
- New approaches to the use of existing BCMA-targeting agents,
- Emerging BCMA-targeting agents
The internationally renowned multiple myeloma expert faculty
- Prof. María-Victoria Mateos: Salamanca, Spain,
- Dr Rakesh Popat: London, UK,
- Prof. Evangelos Terpos: Athens, Greece
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/bcma-mm-comy-eha-2024
touchEXPERT OPINIONS for touchOPHTHALMOLOGY
Listen to leading experts describe the pathophysiology of open-angle glaucoma and discuss how it is targeted by current and emerging treatment options, while providing insights on how different agents and combinations are used in practice.
The experts
- Angelo P Tanna, MD - Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Courtney E Bovee, MD - Bovee Eye, Tampa Bay, FL, USA
- Joseph F Panarelli, MD - NYU Langone Eye Center, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchOPHTHALMOLOGY.com/
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunology.com
touchIN CONVERSATION for touchDERMATOLOGY
Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit our website: touchderma.com
touchFOCUS for touchONCOLOGY
Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma.
The expert
Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Coherus BioSciences. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/touchfocus_evolving-role-of-icis-in-rm-npc/
touchMDT for touchIMMUNOLOGY
Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice.
The multidisciplinary team:
Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling.
The multidisciplinary team and patient advocate:
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchendocrinologyIME.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchENDOCRINOLOGY
Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice.
The multidisciplinary team:
Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchENDOCRINOLOGY
Pruritus in PBC and me: The patient experience
Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).
The multidisciplinary team and patient advocate:
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchDERMATOLOGY
Pruritus in PBC and me: The patient experience
Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).
The multidisciplinary team and patient advocate:
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchDERMATOLOGY
Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice.
The multidisciplinary team:
Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchDERMATOLOGY
Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling.
The multidisciplinary team and patient advocate:
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchIMMUNOLOGY
Pruritus in PBC and me: The patient experience
Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).
The multidisciplinary team and patient advocate:
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchMDT for touchIMMUNOLOGY
Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling.
The multidisciplinary team and patient advocate:
Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany
Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK
Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada
Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK
This touchPODCAST is for HCPs outside of the UK and USA only.This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/
touchCLINICAL PERSPECTIVES for touchRESPIRATORY
Listen to Dr Helena Yu outline the unmet needs and areas for research in metastatic EGFR-mutant NSCLC. Dr Antonio Passaro goes on to review the key clinical trial data in the first- and second-line settings, followed by a discussion of a patient case by Dr Helena Yu to highlight how novel agents and treatment strategies may impact treatment decisions in the clinic.
Course director
Dr Helena Yu, Memorial Sloan Kettering Cancer Center New York, NY, USA
The clinical expert
Dr Antonio Passaro, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from AstraZeneca.
This medical education is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.
For further information visit our website:
touchCLINICAL PERSPECTIVES for touchONCOLOGY
Listen to Dr Helena Yu outline the unmet needs and areas for research in metastatic EGFR-mutant NSCLC. Dr Antonio Passaro goes on to review the key clinical trial data in the first- and second-line settings, followed by a discussion of a patient case by Dr Helena Yu to highlight how novel agents and treatment strategies may impact treatment decisions in the clinic.
Course director
Dr Helena Yu, Memorial Sloan Kettering Cancer Center New York, NY, USA
The clinical expert
Dr Antonio Passaro, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from AstraZeneca.
This medical education is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC.
The experts
- Dr Razelle Kurzrock - Medical Oncologist, Medical College of Wisconsin, Milwaukee, WI, USA
- Dr Lyudmila Bazhenova - Medical Oncologist, UC San Diego Moores Cancer Center, San Diego, CA, USA
- Dr Ignacio Wistuba - Pathologist, MD Anderson Cancer Center, Houston, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/her2_in_solid_tumours_and_nsclc/
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC.
The experts
- Dr Razelle Kurzrock - Medical Oncologist, Medical College of Wisconsin, Milwaukee, WI, USA
- Dr Lyudmila Bazhenova - Medical Oncologist, UC San Diego Moores Cancer Center, San Diego, CA, USA
- Dr Ignacio Wistuba - Pathologist, MD Anderson Cancer Center, Houston, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/her2_in_solid_tumours_and_nsclc/
touchCONGRESS for touchONCOLOGY
Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Dr McDonald
- Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below
Clinical themes
- How does ITP impact the patient and their quality of life?
- What are the latest data that inform the use of current treatments for chronic ITP?
- What data are there for emerging chronic ITP treatments and what do they tell us?
The internationally renowned ITP expert faculty
- Dr Vickie McDonald: London, UK
- Prof. James Bussel: New York, NY, USA,
- Prof. Waleed Ghanima: Oslo, Norway
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi*and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.*
For further information visit our website:
https://touchoncologyime.org/itp-eha-isth-2024/
touchCONGRESS for touchHAEMATOLOGY
Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Dr McDonald
- Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below
Clinical themes
- How does ITP impact the patient and their quality of life?
- What are the latest data that inform the use of current treatments for chronic ITP?
- What data are there for emerging chronic ITP treatments and what do they tell us?
The internationally renowned ITP expert faculty
- Dr Vickie McDonald: London, UK
- Prof. James Bussel: New York, NY, USA,
- Prof. Waleed Ghanima: Oslo, Norway
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi *and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.*
For further information visit our website:
https://touchhaematologyime.org/itp-eha-isth-2024/
touchPANEL DISCUSSION for touchENDOCRINOLOGY
Listen to a panel of experts discuss the benefits of CGM in patients with T2D, strategies to overcome the barriers to its uptake and how to best support patients in implementing CGM.
The experts
- Prof. Stewart Harris, Western University, London, Ontario, Canada,
- Dr Anders Carlson, International Diabetes Center at Park Nicollet, Minneapolis, MN, USA,
- Prof. Shannon Idzik, University of Maryland School of Nursing, Baltimore, MD, USA
This touchPODCAST is for HCPs outside of the UK only.
*This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.*
For further information visit our website:
www.touchENDOCRINOLOGY.com
touchFOCUS for touchONCOLOGY
Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communication strategies and shared decision-making when managing diverse and/or underserved populations with RCC.
The expert
- Prof. Hans Hammers, UT Southwestern, Dallas, TX, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalizing-care-multidisciplinary-team-renal-cell-carcinoma/
touchIN CONVERSATION for touchINFECTIOUS DISEASES
Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV.
The experts
- Dr Christoph Boesecke – University of Bonn, Bonn, Germany
- Dr Tristan Barber – Royal Free London NHS Foundation Trust, London, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical educational grant from ViiV Healthcare. This activity is provided by touchIME.
For further information visit our website:
https://touchinfectiousdiseasesime.org/
touchPANEL DISCUSSION for touchENDOCRINOLOGY
Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease.
The experts
- Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA
- Dr Mario Salvi, University of Milan, Milan, Italy
- Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit:
https://www.touchENDOCRINOLOGY.com
touchPANEL DISCUSSION for touchOPHTHALMOLOGY
Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease.
The experts
- Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA
- Dr Mario Salvi, University of Milan, Milan, Italy
- Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit:
https://www.touchOPHTHALMOLOGY.com
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.
The experts
- Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
- Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
- Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA
This touchPODCAST is for healthcare professionals outside of the UK only.This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchENDOCRINOLOGY.com
touchEXPERT OPINIONS for touchCARDIO
Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.
The experts
- Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
- Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
- Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA
This touchPODCAST is for healthcare professionals outside of the UK only.This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchCARDIO.com
touchEXPERT OPINIONS for touchNEUROLOGY
Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.
The experts
- Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
- Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
- Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA
This touchPODCAST is for healthcare professionals outside of the UK only.This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
www.touchNEUROLOGY.com
touchIN CONVERSATION for touchONCOLOGY
Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of antibody–drug conjugates (ADCs) in the treatment of patients with HER2-positive breast cancer.
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Daiichi Sankyo Europe GmbH and AstraZeneca. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchoncology.com
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.
The experts
- Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
- Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
- Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.
The experts
- Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
- Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
- Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES
Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV.
The experts
- Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Leuven, Belgium
- Prof. José Arribas - La Paz Hospital, Madrid, Spain
- Prof. Antonella Castagna - Vita-Salute San Raffaele University, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.
For further information visit our website:
https://touchinfectiousdiseases.com/
touchIN CONVERSATION for touchRESPIRATORY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.
The experts
- Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
- Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchrespiratoryime.org/her2_nsclc_testing_and_targeted_therapies/
touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights
Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
The experts:
- Prof. John Chen - Mayo Clinic, Rochester, MN, USA
- Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Campus Mitte, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment
touchIN CONVERSATION for touchOPTHAMOLOGY
Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
The experts:
- Prof. John Chen - Mayo Clinic, Rochester, MN, USA
- Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment
touchIN CONVERSATION for touchONCOLOGY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.
The experts
- Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
- Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Pathologist: Dr Eric Gars, Gainesville, FL, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
- Critical care pharmacist: Prof. Rob MacLaren, Denver, CO
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Pathologist: Dr Eric Gars, Gainesville, FL, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
- Critical care pharmacist: Prof. Rob MacLaren, Denver, CO
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
touchIN CONVERSATION for touchNEUROLOGY
Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the importance of early recognition and diagnosis.
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
For further information visit our website: https://touchneurology.com/education/mdt-perspectives-on-management-of-agitation-in-alzheimers-dementia/in-conversation-lets-talk-about-AAD/
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
- Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
- Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
- Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit:
https://touchoncologyime.org/mdt-insights-systemic-mastocytosis
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
- Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
- Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
- Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit:
https://touchhaematologyime.org/mdt-insights-systemic-mastocytosis
touchPANEL DISCUSSION for touchDERMATOLOGY
Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
- Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
- Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
- Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit:
https://touchdermaime.org/mdt-insights-systemic-mastocytosis
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
- Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium
- Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark
- Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit:
https://touchimmunologyime.org/mdt-insights-systemic-mastocytosis
Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.
The expert
- Prof. Heather A Wakelee – Stanford University, CA, USA
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncology.com
Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.
The expert
- Prof. Heather A Wakelee – Stanford University, CA, USA
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncology.com
touchTALKS for touchNEUROLOGY
A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition.
The expert
- Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchneurology.com
touchTALKS for touchCARDIO
A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition.
The expert
- Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchCARDIO.com
touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia
The multidisciplinary team and patient advocate:
MFM specialist - Prof. Karin Blakemore
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike
Otto-von-Guericke University Magdeburg, Magdeburg, Germany
Paediatrician - Prof. Janet Legare
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Patient advocate - Ms Carly Kutner
Freehold, NJ, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/
touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications
The multidisciplinary team and patient advocate:
Paediatrician - Prof. Janet Legare
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike
Otto-von-Guericke University Magdeburg, Magdeburg, Germany
Patient advocate - Ms Carly Kutner
Freehold, NJ, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/
touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications.
The multidisciplinary team and patient advocate:
Paediatrician - Prof. Janet Legare
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
MFM specialist - Prof. Karin Blakemore
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike
Otto-von-Guericke University Magdeburg, Magdeburg, Germany
Patient advocate - Ms Carly Kutner
Freehold, NJ, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/
touchMDT for touchENDOCRINOLOGY
Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals
The multidisciplinary team:
MFM specialist - Prof. Karin Blakemore
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatrician - Prof. Janet Legare
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike
Otto-von-Guericke University Magdeburg, Magdeburg, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/
touchEXPERT OPINIONS for touchONCOLOGY
In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical practice.
The expert
- Prof. Thomas Powles, Barts Cancer Centre, London, UK
This touchPODCAST is for HCPs outside of the UK and USA only.
This activity is funded by an independent medical education grant from Astellas Pharma Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/advanced-urothelial-carcinoma-expert-guidance-to-navigate-an-evolving-therapeutic-landscape
touchEXPERT OPINIONS for touchONCOLOGY
A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice.
The expert
- Prof. David Cibula, General University Hospital and Charles University, Prague, Czech Republic
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck & Co, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.toucONCOLOGY.com
touchEXPERT OPINIONS for touchIMMUNOLOGY
Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options.
The experts
- Dr Michael Perch – University of Copenhagen, Copenhagen, Denmark
- Dr Howard J Huang – Houston Methodist and Weill Cornell Medical College, Houston, TX, USA
- Dr Aldo Iacono – Hofstra University/Northwell Health, Hempstead, NY, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical educational grant from Zambon. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchimmunologyime.org/eo-management-of-bos
touchEXPERT OPINIONS for touchRESPIRATORY
Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options.
The experts
- Dr Michael Perch – University of Copenhagen, Copenhagen, Denmark
- Dr Howard J Huang – Houston Methodist and Weill Cornell Medical College, Houston, TX, USA
- Dr Aldo Iacono – Hofstra University/Northwell Health, Hempstead, NY, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical educational grant from Zambon. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchrespiratoryime.org/eo-management-of-bos
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Juan Manuel O’Connor, a leading expert in colorectal cancer from Argentina, in conversation with Prof. Dr. Francesco Sclafani, a gastrointestinal oncology specialist from Belgium. They respond to questions submitted by the HCP audience and provide their expert insights on the use of precision medicine in the treatment of patients with colorectal cancer.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchoncology.com
touchFOCUS for touchRESPIRATORY
Listen to a medical oncologist share her insights on the current treatments for LS-SCLC and the remaining unmet needs for patients.
The expert
- Dr Anne Chiang – Yale School of Medicine, New Haven, CT, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchrespiratoryime.org/focus-current-treatments-and-unmet-needs-in-LS-SCLC
touchFOCUS for touchONCOLOGY
Listen to a medical oncologist share her insights on the current treatments for LS-SCLC and the remaining unmet needs for patients.
The expert:
- Dr Anne Chiang – Yale School of Medicine, New Haven, CT, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/focus-current-treatments-and-unmet-needs-in-LS-SCLC
touchMDT for touchNEUROLOGY
Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner; they explore the challenges of diagnosing agitation in Alzheimer’s dementia and the importance of a patient-centric multidisciplinary care team that encompasses care partners.
The multidisciplinary team
- Advocate: Ms Jennifer Pettis, Washington DC, USA
- Care partner: Dr Bonnie Burman, New Albany, OH, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
touchMDT for touchNEUROLOGY
Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner to share personal insights of how agitation impacts not only the person living with dementia but everyone around them.
The multidisciplinary team
- Advocate: Ms Jennifer Pettis, Washington DC, USA
- Care partner: Dr Bonnie Burman, New Albany, OH, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss best practice management approaches for agitation in Alzheimer’s dementia.
The multidisciplinary team
- Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA
- Cognitive neurologist: Dr Alireza Atri, Sun City, AZ, USA
- Nurse practitioner: Ms Susan Scanland, Clarks Summit, PA, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss the criteria for diagnosis of agitation in Alzheimer’s dementia; plus, a former care partner shares her insights on the challenges of diagnosis.
The multidisciplinary team
- Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA
- Cognitive neurologist: Dr Alireza Atri, Sun City, AZ, USA
- Nurse practitioner: Ms Susan Scanland, Clarks Summit, PA, USA
- Care partner: Dr Bonnie Burman, New Albany, OH, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team review the behavioural symptoms of agitation in Alzheimer’s dementia, and hear from a former care partner on how agitation impacts not only the person living with dementia but everyone around them.
The multidisciplinary team
- Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA
- Cognitive neurologist: Dr Alireza Atri, Sun City, AZ, USA
- Care partner: Dr Bonnie Burman, New Albany, OH, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
touchIN CONVERSATION for touchENDOCRINOLOGY
Listen to Dr Viswanathan Mohan in conversation with Dr Alice Y Y Cheng. They respond to questions submitted by the HCP audience and provide their expert insights regarding practical considerations for the use of basal insulin therapy in patients with type 2 diabetes, with a focus on the current and future use of continuous glucose monitoring, fixed-ratio combinations and once-weekly basal insulin regimens.
This touchPODCAST is for HCPs outside of the UK and USA.
This activity is funded by an independent medical education grant from Novo Nordisk A/S and is jointly provided by USF Health, EBAC® and touchIME.
For further information visit our website: touchendocrinology.com
touchEXPERT OPINIONS for touchONCOLOGY
Three experts share insights into the unmet treatment needs for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, the rationale for developing additional immunotherapy-based strategies and targeted therapies, and the latest data and ongoing trials for these investigational approaches.
The experts
- Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil
- Prof. Makoto Tahara - National Cancer Center Hospital East, Kashiwa, Japan
- Dr Ranee Mehra - Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an independent medical educational grant from Seagen Inc. and Genmab US, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/future-treatment-of-recurrent-metastatic-scchn/
touchTALKS for touchONCOLOGY
Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs.
The expert
- Dr Rebecca Heist – Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
touchFOCUS for touchIMMUNOLOGY
Listen to Dr Antonella Cianferoni as she answers a series of questions on the diagnosis and management of food allergies.
The expert
- Dr Antonella Cianferoni - Children’s Hospital of Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchimmunologyime.org/expert-insights-in-food-allergy-considerations-for-diagnosis-and-management-in-primary-care-and-beyond/
touchFOCUS for touchRESPIRATORY
Listen to Dr Antonella Cianferoni as she answers a series of questions on the diagnosis and management of food allergies.
The expert
- Dr Antonella Cianferoni - Children’s Hospital of Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchrespiratoryime.org/expert-insights-in-food-allergy-considerations-for-diagnosis-and-management-in-primary-care-and-beyond/
touchTALKS for touchRESPIRATORY
Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs.
The expert
- Dr Rebecca Heist – Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
For further information visit our website: touchrespiratory.com
touchFOCUS for touchRESPIRATORY
Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management.
The expert:
- Dr Ann-Marie Schoos - University of Copenhagen, Denmark
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchimmunology.com
touchFOCUS for touchIMMUNOLOGY
Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management.
The expert:
- Dr Ann-Marie Schoos - University of Copenhagen, Denmark
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchimmunology.com
touchEXPERT OPINIONS for touchHAEMATOLOGY
Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.
The experts
- Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
- Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
- Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchhaematologyime.org/eo-in-rrmm
touchEXPERT OPINIONS for touchONCOLOGY
Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.
The experts
- Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
- Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
- Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/eo-in-rrmm
touchEXPERT OPINIONS for touchIMMUNOLOGY
Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.
The experts:
- Dr Efrem Eren, Southampton General Hospital, UK
- Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USA
- Dr Jamal Hayat, St George's University Hospitals NHS Trust, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: https://touchimmunology.org/eoe-diagnosis-treatment
touchEXPERT OPINIONS for touchRESPIRATORY
Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.
The experts:
- Dr Efrem Eren, Southampton General Hospital, UK
- Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USA
- Dr Jamal Hayat, St George's University Hospitals NHS Trust, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: https://touchrespiratoryime.org/eoe-diagnosis-treatment
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
touchMDT for touchIMMUNOLOGY
Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
touchMDT for touchDERMATOLOGY
Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
touchMDT for touchDERMATOLOGY
Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
touchMDT for touchDERMATOLOGY
Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
touchFOCUS for touchONCOLOGY
A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice.
The expert:
- Dr Vadim Koshkin - University of California San Francisco, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to Dr Shounak Majumder (Mayo Clinic, Rochester, MN, USA) in conversation with Professor Matthias Löhr (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) on how to optimize the diagnosis and management of patients with IgG4-related gastrointestinal (GI) disease.
They respond to questions from the gastroenterology, hepatology and rheumatology clinical communities on:
- Challenges of diagnosing IgG4-related GI disease
- Differentiating type 1 autoimmune pancreatitis from type 2
- Therapeutic strategies for IgG4-related GI disease
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunology.com
touchIN CONVERSATION for touchONCOLOGY
Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
touchIN CONVERSATION for touchHAEMATOLOGY
Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchhaematology.com
touchFOCUS for touchONCOLOGY
Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them.
The expert:
- Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Regeneron. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com/
touchFOCUS for touchRESPIRATORY
Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them.
The expert:
- Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Regeneron. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchrespiratoryime.org/
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy.
This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit our website:touchoncology.com/
touchIN CONVERSATION for touchHAEMATOLOGY
Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy.
This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit our website:https://touchhaematologyime.org/
touchFOCUS for touchOPHTHALMOLOGY
Listen to Dr John Hovanesian answer a series of questions focused on how to effectively manage patients prior to cataract surgery and ensure the most appropriate intraocular lens (IOL) formula is used, including his views on recent advances in IOL technology.
The expert:
- Dr John Hovanesian, University of California, Los Angeles, Jules Stein Eye Institute, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC,. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchophthalmologyime.org/advances-in-iol-technology-and-power-calculations-updates-and-innovations/
touchEXPERT OPINIONS for touchONCOLOGY
Two oncologists summarize the latest US and European guidelines for the treatment of recurrent/metastatic cervical cancer and a nurse practitioner considers key safety considerations for immunotherapy and targeted treatments.
The experts
- Dr David O’Malley - James Comprehensive Cancer Center, Columbus, OH, USA
- Dr Domenica Lorusso - La Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy,
- Courtney Arn – The Ohio State University, Columbus, OH, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Merck and Co., Inc and Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncologyime.org/guideline-management-recurrent-metastatic-cervical-cancer
touchSATELLITE SYMPOSIUM for touchIMMUNOLOGY
Listen to this touchSATELLITE SYMPOSIUM recorded live in November at the ACR Convergence 2023, in San Diego, CA, USA.
Prof. John Stone (USA), the chair for the symposium, is joined by Dr Emanuel Della Torre (Italy) and Dr Arezou Khosroshahi (USA).
The first session, led by Prof. John Stone (02:27), focuses on the pathophysiology and varying clinical presentations of IgG4-related disease (IgG4-RD). This is followed by an audience Q&A (13:11).
The second session, led by Dr Emanuel Della Torre (15:43), reviews the classification criteria for IgG4-RD and how to diagnose the condition. This is followed by an audience Q&A (25:22).
In the third session, Dr Arezou Khosroshahi (29:53) looks at how to treat IgG4-RD and discusses the optimal use of glucocorticoids to induce and maintain remission, and summarizes the targeted treatments for IgG4-RD that are in clinical development. This is followed by an audience Q&A (39:51).
The symposium concludes with a panel discussion and a case presentation (44:06).
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunologyime.org/igg4-related-disease-identify-diagnose-treat/
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms.
The experts
- Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, USA
- Assist. Prof. Nives Pustišek - Children’s Hospital, Zagreb, Croatia
- Prof. Andreas Wollenberg - Ludwig-Maximilian University, Munich, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunologyime.org
touchPANEL DISCUSSION for touchDERMATOLOGY
Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms.
The experts
- Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, USA
- Assist. Prof. Nives Pustišek - Children’s Hospital, Zagreb, Croatia
- Prof. Andreas Wollenberg - Ludwig-Maximilian University, Munich, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchdermaime.org
touchEXPERT OPINIONS for touchNEUROLOGY
A leading multiple sclerosis (MS) specialist shares key considerations for a personalized treatment strategy for patients with relapsing forms of MS, and goes on to explore the key role that B cells play in the pathogenesis and progression of MS, including the therapeutic potential of B-cell–targeted agents.
The expert
- Prof. Martin Weber, University Medical Center Göttingen, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit: touchneurologyime.org/eo-update-on-optimizing-management-of-rms
touchEXPERT OPINIONS for touchOPTHALMOLOGY
Listen to a leading expert in cataract and refractive surgery discuss the key considerations for intraocular lens selection and management of patients with cataracts and ocular comorbidities, including glaucoma, age-related macular degeneration and diabetic retinopathy.
The expert
- Dr Jennifer Loh – Loh Ophthalmology Associates, Miami, FL, USA
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com/education/mab-biosimilars-in-the-treatment-of-solid-tumours-perspectives-for-pharmacists/
touchCONGRESS for touchONCOLOGY
Listen to renowned prostate cancer expert Prof. Oliver Sartor review key data presented at the recent EMSO 2023 congress on new and emerging data that addresses key clinical questions on the use of radiopharmaceuticals in advanced prostate cancer. He also discusses with two additional leading experts, Prof. Francesco Ceci and Dr Heather Jacene, how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Oliver Sartor
- Expert panel discussions with Prof. Francesco Ceci and Dr Heather Jacene on the themes below
Clinical themes
- Refining the use of PSMA-targeted radiopharmaceuticals through optimal patient selections
- Expanding the use of PSMA-targeting radiopharmaceuticals in prostate cancer
- Novel agents and combination approaches to the use of PSMA-targeted radiopharmaceuticals in prostate cancer
The internationally renowned expert faculty
- Prof. Oliver Sartor, Mayo Clinic, Rochester, MN, USA
- Prof. Francesco Ceci, European Institute of Oncology, IRCCS, Milan, Italy
- Dr Heather Jacene, Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications, and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncologyime.org/psma-targeted-radiopharmaceuticals-an-evolving-approach-to-prostate-cancer-management/
touchSATELLITE SYMPOSIUM for touchNEUROLOGY
Listen to this touchSATELLITE SYMPOSIUM on how to optimize diagnosis and care of patients with Alzheimer’s disease (AD), recorded live in October 2023 at the World Neurology Congress 2023 in Montreal, Canada.
Dr Sharon Cohen (behavioural neurologist from Canada), the chair for the symposium, is joined by Prof. Sven Haller (neuroradiologist from Switzerland) and Dr Ronan Factora (geriatrician from the USA).
The first session (03:40), led by Dr Sharon Cohen, focuses on the importance of an early and accurate diagnosis of AD in the DMT era. This is followed by the discussion of a patient case and audience Q&A (24:23).
In the second session (31:27), Prof. Sven Haller discusses the use of imaging and fluid biomarkers in the diagnostic process for. This is followed by the discussion of a patient case and audience Q&A (42:17).
In the third session (54:10), Dr Ronan Factora offers practical insights on how to achieve collaborative patient-centred care across the AD continuum. This is followed by the discussion of a patient case and audience Q&A (01:08:04).
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Eli Lilly and Company and is jointly provided by USF Health and touchIME.
For further information visit our website
touchCLINICAL PERSPECTIVES for touchNEUROLOGY
Listen to our leading expert Prof. Simona Sacco as she looks back over the topics addressed by this modular course, adding her perspectives, highlighting key content and providing insights into the latest real-world data on the burden of migraine and the use of anti-CGRP antibodies for migraine prevention.
The expert
Professor Simona Sacco - University of L’Aquila, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from Eli Lilly and Company Limited.
This medical education is provided by touchIME.
For further information visit our website:
https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/
touchCONGRESS for touchONCOLOGY
Listen to renowned experts in gynaecological oncology Prof. Nicole Concin, Dr Mansoor Raza Mirza and Dr Sandro Pignata review key data presented at ESGO 2023 on recent key developments in the management of patients with endometrial cancer. Aspects covered include the importance of molecular characterization and the latest clinical data for new and emerging agents, including immunotherapies and other agents, in the treatment of advanced or recurrent endometrial cancer. They also discuss how these latest developments may impact clinical practice.
Overview
- Data reviews with Prof. Nicole Concin
- Expert panel discussions with Prof. Nicole Concin, Dr Mansoor Raza Mirza and Dr Sandro Pignata on the themes below
Clinical themes
- Molecular characterization of endometrial cancer: Latest developments
- Efficacy and safety data in advanced or recurrent endometrial cancer: New and emerging immunotherapies
- Efficacy and safety data in advanced or recurrent endometrial cancer: Other emerging agents
The internationally renowned expert faculty
- Prof. Nicole Concin: Innsbruck, Austria,
- Dr Mansoor Raza Mirza: Copenhagen, Denmark,
- Dr Sandro Pignata: Naples, Italy
This touchPODCAST is for HCPs outside of the USA only.
This activity is funded by an independent medical education grant from GlaxoSmithKline, and is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/expanding-horizons-in-the-treatment-of-endometrial-cancer-how-can-data-from-esgo-2023-guide-clinical-practice/#/
touchEXPERT OPINIONS for touchONCOLOGY
A leading expert explores the importance of molecular pathology and individual patient profiles in guiding personalized medicine in thyroid cancer to deliver optimal outcomes.
The expert
- Prof. Marcia Brose, Jefferson Torresdale Hospital, Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bayer HealthCare Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit: touchONCOLOGY.com
touchEXPERT OPINIONS for touchENDOCRINOLOGY
A leading expert explores the importance of molecular pathology and individual patient profiles in guiding personalized medicine in thyroid cancer to deliver optimal outcomes.
The expert
- Prof Marcia Brose, Jefferson Torresdale Hospital, Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bayer HealthCare Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit: touchENDOCRINOLOGY.com
Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.
The experts
- Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada
- Prof. Dr. med. Oliver Cornely – University of Cologne, Germany
- Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Moderna. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchinfectiousdiseases.com/
Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.
The experts
- Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada
- Prof. Dr. med. Oliver Cornely – University of Cologne, Germany
- Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Moderna. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchrespiratory.com/
touchIN CONVERSATION for touchOPHTHALMOLOGY
In this activity, listen to ophthalmology experts, Prof. Sumit Garg and Dr Karolinne Rocha, respond to questions from the ophthalmology community on IOL selection in cataract patients, focusing on the preoperative assessment of ocular health, optimizing IOL calculations, and the impact of previous surgeries on lens selection.
This touchPODCAST is for healthcare professionals only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: touchOPHTHALMOLOGY
touchCLINICAL PERSPECTIVES for touchNEUROLOGY
Listen to two case-based interviews with migraine specialists focusing on preventive treatment of migraine with anti-CGRP antibodies. In the first, a clinical expert shares his perspectives on treatment failure in patients with migraine, providing insights and guidance, while the second discussion considers different clinical scenarios to focus on practical management.
The experts:
Prof. Christian Lampl, Konventhospital Barmherzige Brüder, Linz, Austria Dr Simy Parikh, Thomas Jefferson University Hospital, Philadelphia, PA, USA
This touchPODCAST is for HCPs only. This activity is funded by an educational grant from Eli Lilly and Company Limited. This medical education is provided by touchIME.
For further information visit our website: https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations.
In Part 1 they respond to questions from the oncology and respiratory clinical communities on:
- Biomarker testing in advanced NSCLC
- Identifying patients with METex14 skipping mutations
- Targeting METex14 skipping mutations
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck KGaA. This activity is jointly provided by USF Health and touchIME
For further information visit our website: TBC
touchIN CONVERSATION for touchRESPIRATORY
Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations.
In Part 1 they respond to questions from the oncology and respiratory clinical communities on:
- Biomarker testing in advanced NSCLC
- Identifying patients with METex14 skipping mutations
- Targeting METex14 skipping mutations
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck KGaA. This activity is jointly provided by USF Health and touchIME
For further information visit our website: TBC
touchPANEL DISCUSSION for touchOPHTHALMOLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
- Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
- Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA
This touchPODCAST is for HCPs only.
An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchOPHTHALMOLOGY
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
- Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
- Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA
This touchPODCAST is for HCPs only.
An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchIMMUNOLOGY
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
- Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
- Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA
This touchPODCAST is for HCPs only.
An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchNEUROLOGY
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
The experts
- Prof. Biree Andemariam, Farmington, CT, USA
- Prof. Modupe Idowu, Houston, TX, USA
- Prof. Mark C Walters, Oakland, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: TBC
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
The experts
- Prof. Biree Andemariam, Farmington, CT, USA;
- Prof. Modupe Idowu, Houston, TX, USA;
- Prof. Mark C Walters, Oakland, CA, USA;
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: TBC
touchPANEL DISCUSSION for touchCARDIO
Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
The experts
- Prof. Biree Andemariam, Farmington, CT, USA;
- Prof. Modupe Idowu, Houston, TX, USA;
- Prof. Mark C Walters, Oakland, CA, USA;
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: TBC
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three expert haematologists discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
The experts
- Prof. Biree Andemariam, Farmington, CT, USA;
- Prof. Modupe Idowu, Houston, TX, USA;
- Prof. Mark C Walters, Oakland, CA, USA;
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals Inc., Pfizer and Vertex Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: TBC
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three breast cancer experts discuss the expanding targeted treatment options for HER2-negative metastatic breast cancer, with a focus on approved and emerging antibody drug conjugates and considerations for their use in clinical practice.
The experts
- Prof. Giuseppe Curigliano, University of Milan, Milan, Italy
- Prof. Hope Rugo, University of California, San Francisco, CA, USA
- Prof. Peter Schmid, Barts Cancer Institute, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/new-and-emerging-agents-in-her2negative-mbc
touchEXPERT OPINIONS for touchNEUROLOGY
Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes.
The experts:
- Prof. Hanne Christensen, University of Copenhagen, Denmark
- Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany
- Dr Truman Milling, The University of Texas at Austin, TX, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit: https://touchneurologyime.org/reversal_agents_for_DOAC-ICH
touchEXPERT OPINIONS for touchCARDIOLOGY
Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes.
The experts:
- Prof. Hanne Christensen, University of Copenhagen, Denmark
- Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany
- Dr Truman Milling, The University of Texas at Austin, TX, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit: https://touchcardiologyime.org/reversal_agents_for_DOAC-ICH
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the case-based implementation of immune checkpoint inhibitors in endometrial cancer through shared decision making.
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-for-ici-in-ec/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
- Pathologist: Dr Tjalling Bosse, Leiden, Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-for-ici-in-ec/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss improving outcomes with immune checkpoint inhibitors in advanced or recurrent endometrial cancer.
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/mdt-for-ici-in-ec/
touchIN CONVERSATION for touchHAEMATOLOGY
Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis.
They respond to questions submitted by the HCP audience and provide expert insights on:
- The key considerations when selecting a first-line JAK inhibitor
- How to best manage side effects associated with JAK inhibitors
- The treatment options following failure on a first-line JAK inhibitor
This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchhaematologyime.org/in-conversation-jak-inhibition-in-myelofibrosis
touchIN CONVERSATION for touchONCOLOGY
Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis.
They respond to questions submitted by the HCP audience and provide expert insights on:
- The key considerations when selecting a first-line JAK inhibitor How to best manage side effects associated with JAK inhibitors The treatment options following failure on a first-line JAK inhibitor
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/in-conversation-jak-inhibition-in-myelofibrosis
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake.
The experts:
- Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa,
- Prof. Eduardo Franco OC, McGill University, Montreal, Canada,
- Prof. Daniel Kelly OBE, European Cancer Organisation, HPV Action Network, Cardiff, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME.
For further information visit: touchONCOLOGY
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES
Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake.
The experts:
- Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa,
- Prof. Eduardo Franco OC, McGill University, Montreal, Canada,
- Prof. Daniel Kelly OBE, European Cancer Organisation HPV Action Network, Cardiff, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME.
For further information visit: touchINFECTIOUS DISEASES
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer.
The experts
- Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK;
- Dr Andrea Cercek - Memorial Sloan Kettering Cancer Center, New York, NY, USA;
- Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain;
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Seagen Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website: TBC
touchCLINICAL PERSPECTIVES for touchNEUROLOGY - Module 1 & 2
Module 1
Listen first to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options.
The expert Professor Simona Sacco - University of L’Aquila, Italy
Module 2
Listen next to a patient advocate providing her insights on the burden of migraine for patients and then to a clinical expert as he shares his perspectives on how real-world data for anti-CGRP antibodies can inform treatment optimization.
The patient advocate Ms Elena Ruiz de la Torre - European Migraine & Headache Alliance, Spain
The clinical expert Professor Mamoru Shibata - Ichikawa General Hospital, Chiba, Japan
- This touchPODCAST is for HCPs only.
- This activity is funded by an educational grant from Eli Lilly and Company Limited.
- This medical education is provided by touchIME.
For further information visit our website: https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/
touchCLINICAL PERSPECTIVES for touchNEUROLOGY
Recognizing the burden of migraine in daily life and real-world insights on anti-CGRP antibodies for migraine prevention
Listen first to a patient advocate providing her insights on the burden of migraine for patients and then to a clinical expert as he shares his perspectives on how real-world data for anti-CGRP antibodies can inform treatment optimization.
The patient advocate Ms Elena Ruiz de la Torre - European Migraine & Headache Alliance, Spain
The clinical expert Professor Mamoru Shibata - Ichikawa General Hospital, Chiba, Japan
This touchPODCAST is for HCPs only. This activity is funded by an educational grant from Eli Lilly and Company Limited. This medical education is provided by touchIME.
For further information visit our website: https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration.
The experts:
Part 1
- Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
- Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Part 2
- Prof. Jorge Garcia, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
- Dr Jason Starr, Mayo Clinic, Jacksonville, FL, USA
- Dr Erik Mittra, Oregon Health and Science University, Portland, OR, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.
For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/
Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives.
The expert
- Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchONCOLOGY
Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives.
The expert
- Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchRESPIRATORY
touchEXPERT OPINIONS for touchONCOLOGY
Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration.
The experts
Part 1
- Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
- Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Part 2
- Jorge Garcia, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
- Dr Jason Starr, Mayo Clinic, Jacksonville, FL, USA
- Dr Erik Mittra, Oregon Health and Science University, Portland, OR, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/radiopharmaceuticals-adult-oncology-primer
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES
Listen to a panel of experts discuss the importance of optimizing antiretroviral therapy through an individualized approach to care and shared decision making.
The experts
- Prof Jens Lundgren, University of Copenhagen, Hvidovre, Denmark
- Prof Marta Boffito, Chelsea and Westminster Hospital and Imperial College London, UK
- Ms Angelina Namiba, 4M Network, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.
For further information visit: https://touchinfectiousdiseases.com/
touchSATELLITE SYMPOSIUM for touchOPHTHALMOLOGY
Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers.
Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA).
The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed by audience Q&A (12:38).
The second session, led by Dr Jeffrey Bennett (15:57), discusses the latest efficacy and safety data on immunotherapies for NMOSD, and the factors influencing clinical decision making in daily practice. This is followed by audience Q&A (30:48).
In the third session, Dr Dalia Rotstein (34:49) summarizes the wider clinical symptoms of NMOSD and multidisciplinary strategies to mitigate the burden of disease. This is followed by a panel discussion in which the faculty provide their insights on selected Q&A from the audience (39:30).
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/nmosd-latest-developments/
touchSATELLITE SYMPOSIUM for touchNEUROLOGY
Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers.
Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA).
The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed by audience Q&A (12:38).
The second session, led by Dr Jeffrey Bennett (15:57), discusses the latest efficacy and safety data on immunotherapies for NMOSD, and the factors influencing clinical decision making in daily practice. This is followed by audience Q&A (30:48).
In the third session, Dr Dalia Rotstein (34:49) summarizes the wider clinical symptoms of NMOSD and multidisciplinary strategies to mitigate the burden of disease. This is followed by a panel discussion in which the faculty provide their insights on selected Q&A from the audience (39:30).
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/nmosd-latest-developments/
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM.
The experts
- Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA
- Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA
- Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchhaematologyime.org/
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM.
The experts:
- Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA
- Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA
- Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchoncology.com/
touchIN CONVERSATION for touchNEUROLOGY
Listen to Dr Ruth Dobson (UK) in conversation with Dr Ide Smets (The Netherlands). They discuss questions submitted by the healthcare professional (HCP) audience and provide their expert insights on the practicalities of therapeutic sequencing options in multiple sclerosis (MS).
Clinical themes:
- Factors guiding the use of high-efficacy disease-modifying therapies (DMTs) in the management of active MS (02:01)
- Current approaches and safety considerations relating to DMT switching and sequencing in MS (14:17)
- Approaches needed to support women of child-bearing age living with MS through family planning and beyond (23:38)
This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity was led by USF Health and touchIME.
For further information visit our website: www.touchneurology.com/individualizing-long-term-treatment-and-care-in-MS/
Listen to key experts from a multidisciplinary team review the role of biomarkers in informing immune checkpoint inhibitor use across tumour types.
The multidisciplinary team
- Medical oncologist: Prof. Ken Kato, Tokyo, Japan
- Pathologist: Prof. Albrecht Stenzinger, Heidelberg, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.For further information visit our website: touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the approaches for managing immune-related adverse events.
The multidisciplinary team
- Medical oncologist: Prof. Ken Kato, Tokyo, Japan
- Oncology nurse: Ms Tara Hurley, Sutton, UK
- Clinical oncology pharmacist: Dr Alison Palumbo, Oregon, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.For further information visit our website: touchONCOLOGY
Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events.
The multidisciplinary team
- Medical oncologist: Prof. Ken Kato, Tokyo, Japan
- Oncology nurse: Ms Tara Hurley, Sutton, UK
- Clinical oncology pharmacist: Dr Alison Palumbo, Oregon, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the current and upcoming indications for immune checkpoint inhibitors in patients with solid tumours and review general considerations for their use.
The multidisciplinary team
- Medical oncologist: Prof. Ken Kato, Tokyo, Japan
- Oncology nurse: Ms Tara Hurley, Sutton, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchONCOLOGY
touchPANEL DISCUSSION for touchONCOLOGY
Listen to an oncologist, urologist and nurse discuss adverse event identification and management with immunotherapies and targeted therapies for locally advanced or metastatic urothelial carcinoma.
The experts
- Dr Axel Merseburger, University Hospital Schleswig-Holstein, Campus Lübeck, Germany
- Dr André Fay, PUCRS School of Medicine, Porto Alegre, Brazil
- Ms Maria Lapuente, St Bartholomew’s Hospital, London, UK
This touchPODCAST is for HCPs outside the US only.
This activity is funded by an independent medical education grant from Astellas Inc. and Seagen Inc., and is jointly provided by USF Health and touchIME.
For further information please visit: touchONCOLOGY
touchIN CONVERSATION for touchINFECTIOUS DISEASES
Listen to Dr Farhan Fazal in conversation with Dr Nada Melhem. They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine uptake in the Middle East.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Moderna, Inc. This activity was led by USF Health and touchIME.
For further information visit our website: https://touchinfectiousdiseasesime.org/in-conversation-practical-considerations-covid19-vaccination-middle-east/
touchCLINICAL PERSPECTIVES for touchNEUROLOGY
Listen to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options.
The expert
Professor Simona Sacco - University of L’Aquila, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from Eli Lilly and Company Limited.
This medical education is provided by touchIME.
For further information visit our website:
https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/
touchEXPERT OPINIONS for touchENDOCRINOLOGY
In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology.
The experts
- Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
- Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.
For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/
touchEXPERT OPINIONS for touchONCOLOGY
In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology.
The experts
- Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
- Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/radiopharmaceuticals-adult-oncology-primer/
touchIN CONVERSATION for touchINFECTIOUS DISEASES
Listen to Dr John Amuasi in conversation with Dr Christina Obiero. They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine uptake in Africa.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Moderna, Inc. This activity was led by USF Health and touchIME.
For further information visit our website: www.touchinfectiousdiseases.com
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts sharing their perspectives on the impact of the 2022 guideline updates on diagnosis, classification and management of higher-risk myelodysplastic neoplasms (MDS) and acute myeloid leukaemia (AML).
The experts
- Prof. Andrew Wei, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
- Prof. Agnieszka Wierzbowska, Medical University of Lodz, Poland
- Prof. Gert Ossenkoppele, Vrije Universiteit University Medical Center, Amsterdam, Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis and is provided by touchIME.
For further information visit: www.touchoncology.com/education/impact-of-new-guidelines-in-MDS-AML
touchEXPERT OPINIONS for touchHAEMATOLOGY
Listen to three leading experts sharing their perspectives on the impact of the 2022 guideline updates on diagnosis, classification and management of higher-risk myelodysplastic neoplasms (MDS) and acute myeloid leukaemia (AML).
The experts
- Prof. Andrew Wei, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
- Prof. Agnieszka Wierzbowska, Medical University of Lodz, Poland
- Prof. Gert Ossenkoppele, Vrije Universiteit University Medical Center, Amsterdam, Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis and is provided by touchIME.
For further information visit: www.touchhaematology.com/education/impact-of-new-guidelines-in-MDS-AML
touchCONGRESS for touchONCOLOGY
Listen to renowned experts in gynaecological oncology Dr Domenica Lorusso, Dr Susana Banerjee and Prof. Frederik Marmé review key data presented at SGO 2023 on recent developments in the use of PARP inhibitors in ovarian cancer. Aspects covered include first-line maintenance therapy, selection and sequencing implications, and future directions including emerging neoadjuvant and combination regimens. They also discuss how these latest data may impact clinical practice.
Overview
- Data reviews with Dr Domenica Lorusso, Dr Susana Banerjee and Prof. Frederik Marmé
- Expert panel discussions with Dr Domenica Lorusso, Dr Susana Banerjee and Prof. Frederik Marmé on the themes below
Clinical themes
- Update on first-line PARP inhibitor maintenance in ovarian cancer: Where are we now? (02:31)
- Selection and sequencing implications for PARP inhibitors in ovarian cancer emerging from the latest data: What should we consider, and when? (19:51)
- Emerging PARP inhibitor-based neoadjuvant and combination regimens in ovarian cancer: Where are we heading? (40:10)
The internationally renowned expert faculty
- Dr Domenica Lorusso: Rome, Italy,
- Dr Susana Banerjee: London, UK,
- Prof. Frederik Marmé: Mannheim, Germany
This touchPODCAST is for HCPs outside of the USA only.
This activity is funded by an independent medical education grant from GlaxoSmithKline, and is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/congress-sgo-2023-updates-parp-inhibitors-ovarian-cancer/#
touchSATELLITE SYMPOSIUM for touchNEUROLOGY
Listen to this touch satellite symposium recorded live in March 2023 at the AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders.
Prof. Jeffrey Cummings (USA), the chair for the symposium, is joined by Prof. Liana Apostolova (USA), Prof. Oskar Hansson (Sweden) and Prof. Charlotte Teunissen (The Netherlands).
The first session, led by Prof. Liana Apostolova (05:44), focuses on the importance of a timely and accurate diagnosis based on the underlying pathophysiology of Alzheimer’s disease (AD) and how this informs the ATN classification system for AD biomarkers. This is followed by audience Q&A (18:30).
The second session, led by Prof. Oskar Hansson (33:09), discusses the validity and performance data for AD blood-based biomarkers in comparison to current neuroimaging. This is followed by audience Q&A (49:12).
In the third session, Prof. Charlotte Teunissen (01:01:05) looks at how blood-based biomarkers may revolutionize the diagnostic and prognostic work-up of AD and improve the design of interventional trials, with the potential to be easily accessible for widespread clinical use. This is followed by audience Q&A (01:18:48).
The symposium concludes with a panel discussion in which the faculty provide their insights on selected Q&A from the audience (01:29:40).
This activity is funded by an independent medical education grant from Eli Lilly and Company. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchNEUROLOGY
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES
Listen to a panel of regional experts discuss the current landscape of COVID-19 vaccination, possible barriers to vaccine uptake and strategies involving healthcare workers that may help to improve acceptance of the COVID-19 vaccine, with a focus on Africa and the Middle East.
The experts
- Dr Angus Thomson, IRIMI company, Lyon, France
- Dr Amaya Gillespie, WHO/UNICEF, Jordan
- Dr Henry Kyobe Bosa, Ministry of Health, Uganda
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Moderna, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchinfectiousdiseases.com
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three experts provide their insights on unmet needs, emerging therapies, and the importance of biomarker testing in HER2-negative gastric cancer/gastroesophageal junction cancer
The experts
- Dr Reetu Mukherji - MedStar Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA,
- Dr Jaffer Ajani - Houston, TX, USA,
- Dr Nataliya Uboha - University of Wisconsin, Madison, WI, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Astellas Pharma Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/exp_opin_HER2_negative_gastric_or_GE_junction_cancer
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the role of biomarkers in optimizing the treatment of colorectal cancer, and how biomarkers are shaping the evolving treatment landscape.
The experts
- Dr Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan
- Dr Chiara Cremolini, University of Pisa, Pisa, Italy
- Dr Rachel Riechelmann, AC Camargo Cancer Center, São Paulo, Brazil
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information please visit: TBC
touchCONGRESS for touchONCOLOGY
Listen to renowned renal cell carcinoma (RCC) expert Prof. Brian Rini review key data presented at the ASCO GU 2023 congress on advances in immune checkpoint inhibitor (ICI)-based regimens for RCC. He also discusses with two additional leading RCC experts, Prof. Elizabeth Plimack and Prof. Thomas Powles, how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Rini,
- Expert panel discussions with Prof. Rini, Prof. Plimack and Prof. Powles on the themes below
Clinical themes
- ICI-based combinations in the treatment of advanced/metastatic RCC: What do the latest efficacy and safety data show?
- What is the potential role of biomarkers in predicting response to ICI-based combinations in patients with advanced/metastatic RCC?
- How might the latest data for ICI-based combinations for advanced/metastatic RCC be implemented in clinical practice?
The internationally renowned RCC expert faculty
- Prof. Brian Rini: Nashville, TN, USA,
- Prof. Elizabeth Plimack: Philadelphia, PA, USA,
- Prof. Thomas Powles: London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co. Inc. and Exelixis Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website: touchONCOLOGY
touchEXPERT OPINIONS for touchtouchRESPIRATORY
Listen to three experts as they share their perspectives and best-practice guidance on how to optimize the diagnosis and management of pulmonary arterial hypertension.
The experts
- Prof. Harrison Farber, Tufts Medical Center, Boston, MA, USA
- Prof. Marion Delcroix, University Hospitals Leuven, Belgium
- Prof. Stephan Rosenkranz, Pulmonary Hypertension Center, University of Cologne, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co. and is jointly provided by USF Health and touchIME.For further information visit our website: touchRESPIRATORY
touchEXPERT OPINIONS for touchCARDIO
Listen to three experts as they share their perspectives and best-practice guidance on how to optimize the diagnosis and management of pulmonary arterial hypertension.
The experts
- Prof. Harrison Farber, Tufts Medical Center, Boston, MA, USA
- Prof. Marion Delcroix, University Hospitals Leuven, Belgium
- Prof. Stephan Rosenkranz, Pulmonary Hypertension Center, University of Cologne, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co. and is jointly provided by USF Health and touchIME.For further information visit our website: touchCARDIO
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of three oncology pharmacists discuss how to improve outcomes for patients experiencing immune-related adverse events after receiving immunotherapy for cancer treatment.
The experts
- Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA
- Ms Meera Desai, University College London Hospitals NHS Foundation Trust, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from MSD and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/pharmacist-role-iraes/
touchMDT for touchENDOCRINOLOGY
An endocrinologist, a pituitary surgeon and a pituitary nurse specialist review treatment pathways for patients with Cushing’s disease, with a focus on medical therapies, and provide insights on the efficacy and safety of approved medical agents.
- Pituitary surgeon: Dr Timothy Smith, Boston, MA, USA,
- Endocrinologist: Dr Laurence Katznelson, Stanford, CA, USA,
- Pituitary nurse specialist: Mrs Sandra Ramsburg, Baltimore, MD, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Recordati Rare Diseases and Xeris Pharmaceuticals, Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website:
touchENDOCRINOLOGY
touchMDT for touchENDOCRINOLOGY
An endocrinologist, a pituitary surgeon, a pituitary nurse specialist and a patient with Cushing's disease in remission share their views on how the multidisciplinary team can support patients with Cushing’s disease.
The multidisciplinary team
- Pituitary surgeon: Dr Timothy Smith, Boston, MA, USA,
- Endocrinologist: Dr Laurence Katznelson, Stanford, CA, USA,
- Pituitary nurse specialist: Mrs Sandra Ramsburg, Baltimore, MD, USA,
- Patient in remission/patient advocate: Ms Sharmyn McGraw, Orange County, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Recordati Rare Diseases and Xeris Pharmaceuticals, Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website:
touchENDOCRINOLOGY
touchMDT for touchENDOCRINOLOGY
A pituitary surgeon, an endocrinologist and a patient with Cushing’s disease in remission discuss management challenges, including diagnostic delay and associated comorbidities, and the goals of medical therapy in Cushing’s disease.
The multidisciplinary team
- Pituitary surgeon: Dr Timothy Smith, Boston, MA, USA,
- Endocrinologist: Dr Laurence Katznelson, Stanford, CA, USA,
- Patient in remission/patient advocate: Ms Sharmyn McGraw, Orange County, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Recordati Rare Diseases and Xeris Pharmaceuticals, Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website:
touchENDOCRINOLOGY
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the role of biomarkers in optimizing the treatment of colorectal cancer, and how biomarkers are shaping the evolving treatment landscape.
The experts
- Dr Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan
- Dr Chiara Cremolini, University of Pisa, Pisa, Italy
- Dr Rachel Riechelmann, AC Camargo Cancer Center, São Paulo, Brazil
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information please visit: TBC to be added by PM on day of launch
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team review novel approaches to overcome resistance to standard-of-care immunotherapy for non-driver mutation metastatic NSCLC, including new immune checkpoint inhibitor combinations and emerging novel targets.
The multidisciplinary team
- Oncology Pharmacist: Prof. Lisa Holle, CT, USA
- Medical Oncologist: Prof. Raffaele Califano, Manchester, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the tools used to predict response to immunotherapy, and they review emerging biomarkers.
The multidisciplinary team
- Pathologist: Prof. Albrecht Stenzinger, Heidelberg, Germany
- Medical Oncologist: Prof. Raffaele Califano, Manchester, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, plus a survivor of metastatic NSCLC, discuss the importance of involving patients in their treatment decisions and how clinicians can best support patients throughout their treatment journey.
The multidisciplinary team
- Medical Oncologist: Prof. Raffaele Califano, Manchester, UK
- Oncology Pharmacist: Prof. Lisa Holle, CT, USA
- Patient Advocate: Mr Josh Colow, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the challenges associated with standard-of-care immunotherapy for metastatic NSCLC without driver mutations, including treatment resistance and toxicity.
The multidisciplinary team
- Medical Oncologist: Prof. Raffaele Califano, Manchester, UK
- Oncology Pharmacist: Prof. Lisa Holle, CT, USA
- Pathologist: Prof. Albrecht Stenzinger, Heidelberg, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease.
The experts
- Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA
- Dr Hanny Al-Samkari, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Prof. Ami J Shah, Lucile Packard Children’s Hospital Stanford, and Stanford University, Palo Alto, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Agios Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: TBC
touchPANEL DISCUSSION for touchENDOCRINOLOGY
Listen to a radiologist, a nephrologist and a primary care physician discuss how to predict progression and prognosis in ADPKD, as well as current and emerging treatment options for rapidly progressing disease, and how to manage potential side effects.
The experts
- Prof. Bradley Erickson, Mayo Clinic College of Medicine and Science, Rochester, MN, USA,
- Prof. Neera Dahl, Yale University, Yale School of Medicine, New Haven, CT, USA,
- Prof. Charles Vega, UCI Health, Santa Ana, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Otsuka America. This activity is jointly provided by USF Health and touchIME.
For further information visit: https://touchendocrinologyime.org/clinical-management-of-rapidly-progressing-ADPKD
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease.
The experts
- Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA
- Dr Hanny Al-Samkari, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Prof. Ami J Shah, Lucile Packard Children’s Hospital Stanford, and Stanford University, Palo Alto, CA, USA
This touchPODCAST is for HCPs only.This activity is funded by an independent medical education grant from Agios Pharmaceuticals and is jointly provided by USF Health and touchIME.For further information visit: TBC
Listen to key experts from a multidisciplinary team discuss novel pharmacological and gene therapies that are available or emerging for the management of DMD.The multidisciplinary team
- Neurologist: Prof. Nancy Kuntz, Chicago, IL, USA
- Geneticist: Dr Nadia Merchant, Washington, DC, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This medical education is jointly provided by USF Health and touchIME.For further information visit our website: www.touchneurology.com
Listen to key experts from a multidisciplinary team discuss established treatments and the importance of the multidisciplinary team in the management of DMD
The multidisciplinary team
- Paediatrician: Dr Laura Kauffman, Chicago, IL, USA
- Geneticist: Dr Nadia Merchant, Washington, DC, USA
- Neurologist: Prof. Nancy Kuntz, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This medical education is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchneurology.com
Listen to key experts from a multidisciplinary team, plus a patient advocate who is the parent of a patient with DMD, discuss the key considerations for the diagnosis of DMD and pre-symptomatic screening for the condition.The multidisciplinary team
- Neurologist: Prof. Nancy Kuntz, Chicago, IL, USA
- Geneticist: Dr Nadia Merchant, Washington, DC, USA
- Patient advocate: Mr Filippo Buccella, Rome, Italy
This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics.This medical education is jointly provided by USF Health and touchIME.For further information visit our website: www.touchneurology.com
Listen to key experts from a multidisciplinary team, plus a patient advocate who is the parent of a patient with DMD, discuss the traditional and non-traditional signs and symptoms of the condition.The multidisciplinary team
- Paediatrician: Dr Laura Kauffman, Chicago, IL, USA
- Neurologist: Prof. Nancy Kuntz, Chicago, IL, USA
- Patient advocate: Mr Filippo Buccella, Rome, Italy
This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics.This medical education is jointly provided by USF Health and touchIME.For further information visit our website: www.touchneurology.com
touchTALKS for touchNEUROLOGY
Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifying therapies, and reviews the mechanism of action and clinical trial landscape for Bruton’s tyrosine kinase inhibitors.
The expert
- Prof. Tobias Derfuss, University Hospital Basel, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website www.touchneurology.com
touchTALKS for touchIMMUNOLOGY
Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifying therapies, and reviews the mechanism of action and clinical trial landscape for Bruton’s tyrosine kinase inhibitors.
The expert
- Prof. Tobias Derfuss, University Hospital Basel, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website www.touchimmunology.com
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.
The expert
- Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchendocrinology.org
touchEXPERT OPINIONS for touchRESPIRATORY
Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.
The expert
- Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchrespiratory.org
touchEXPERT OPINIONS for touchNEUROLOGY
Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.
The expert
- Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchneurology.org
touchMDT for touchONCOLOGY
A medical oncologist and a pathologist discuss HER2 testing in patients with colorectal cancer, including when and how to test, and the interpretation of test results.
The multidisciplinary team
- Medical oncologist: Prof. Andrea Sartore-Bianchi, Milan, Italy
- Pathologist: Dr Evgeny Yakirevich, Providence, RI, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/
touchMDT for touchONCOLOGY
A medical oncologist, advanced practice nurse and patient advocate discuss possible side effects of colorectal cancer treatments and how they can be managed in the multidisciplinary team setting.
The multidisciplinary team
- Medical oncologist: Dr Kristen Ciombor, Nashville, TN, USA
- Advanced practice nurse: Dr Kelley Rone, Phoenix, AZ, USA
- Patient advocate: Mr Scott Wilson, Denver, CO, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/
touchMDT for touchONCOLOGY
A medical oncologist, advanced practice nurse and patient advocate share their views on how the multidisciplinary team can support patients with HER2-positive colorectal cancer.
The multidisciplinary team
- Medical oncologist: Dr Kristen Ciombor, Nashville, TN, USA
- Advanced practice nurse: Dr Kelley Rone, Phoenix, AZ, USA
- Patient advocate: Mr Scott Wilson, Denver, CO, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/
touchMDT for touchONCOLOGY
Two medical oncologists discuss the latest clinical trial data for HER2-targeted treatments in colorectal cancer (CRC), how they utilize these agents in clinical practice, and what the future holds for HER2-targeting in CRC.
The multidisciplinary team
- Medical oncologists: Dr Kristen Ciombor, Nashville, TN, USA and Prof. Andrea Sartore-Bianchi, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC.
The experts
- Prof. Jarushka Naidoo, Beaumont RCSI Cancer Centre, Dublin, Ireland
- Dr Rebecca Heist, Massachusetts General Hospital Cancer Center, Boston, MA, USA
- Dr Antonio Passaro, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is provided by touchIME.
For further information visit: www.https://touchoncology.com/
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma.
The multidisciplinary team
- Paediatric immunologist: Dr Wanda Phipatanakul
- Primary care physician: Dr Ioanna Tsiligianni
- Specialist asthma nurse: Ms Viv Marsh
- Patient advocate: Ms Monique Cooper
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma.
The multidisciplinary team
- Paediatric immunologist: Dr Wanda Phipatanakul
- Primary care physician: Dr Ioanna Tsiligianni
- Specialist asthma nurse: Ms Viv Marsh
- Patient advocate: Ms Monique Cooper
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-severe-paediatric-asthma
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma.
The multidisciplinary team
- Paediatric pulmonologist: Dr Atul Gupta
- Paediatric immunologist: Dr Wanda Phipatanakul
- Primary care physician: Dr Ioanna Tsiligianni
- Specialist asthma nurse: Ms Viv Marsh
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma.
The multidisciplinary team
- Paediatric pulmonologist: Dr Atul Gupta
- Paediatric immunologist: Dr Wanda Phipatanakul
- Primary care physician: Dr Ioanna Tsiligianni
- Specialist asthma nurse: Ms Viv Marsh
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-severe-paediatric-asthma
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.
The multidisciplinary team
- Paediatric pulmonologist: Dr Atul Gupta
- Paediatric immunologist: Dr Wanda Phipatanakul
- Patient advocate: Ms Monique Cooper
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.
The multidisciplinary team
- Paediatric pulmonologist: Dr Atul Gupta
- Paediatric immunologist: Dr Wanda Phipatanakul
- Patient advocate: Ms Monique Cooper
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-severe-paediatric-asthma
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions.
The multidisciplinary team
- Paediatric pulmonologist: Dr Atul Gupta
- Paediatric immunologist: Dr Wanda Phipatanakul
- Primary care physician: Dr Ioanna Tsiligianni
- Patient advocate: Ms Monique Cooper
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions.
The multidisciplinary team
- Paediatric pulmonologist: Dr Atul Gupta
- Paediatric immunologist: Dr Wanda Phipatanakul
- Primary care physician: Dr Ioanna Tsiligianni
- Patient advocate: Ms Monique Cooper
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-severe-paediatric-asthma
touchTALKS for touchONCOLOGY
Listen to a leading expert in higher-risk myelodysplastic neoplasms (HR-MDS) discuss the impact that emerging treatment options may have on clinical practice. He covers the latest updates to the classification of HR-MDS, the mode of action of emerging therapeutic agents and the most recent clinical evidence on their efficacy and safety.
The expert
- Dr David Sallman, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchoncology.com
Video 1 Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting
The multidisciplinary team
- Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
- Oncology pharmacist: Dr Sonia Amin Thomas, Georgia, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
Video 3 Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life
The multidisciplinary team
- Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
- Oncology nurse practitioner: Dr Victoria Sherry, Pennsylvania, USA
- Oncology pharmacist: Dr Sonia Amin Thomas, Georgia, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
Video 2 Listen to key experts from a multidisciplinary team discuss how side effects of SCLC treatment and patient performance status impact treatment selection and prognosis, and the potential for molecular classification to determine future treatment options
The multidisciplinary team
- Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
- Pulmonologist: Dr Christine Argento, Maryland, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
Video 3 Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life
The multidisciplinary team
- Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
- Oncology nurse practitioner: Dr Victoria Sherry, Pennsylvania, USA
- Oncology pharmacist: Dr Sonia Amin Thomas, Georgia, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
Video 2 Listen to key experts from a multidisciplinary team discuss how side effects of SCLC treatment and patient performance status impact treatment selection and prognosis, and the potential for molecular classification to determine future treatment options
The multidisciplinary team
- Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
- Pulmonologist: Dr Christine Argento, Maryland, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
Video 1 Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting
The multidisciplinary team
- Medical oncologist: Dr Barbara Melosky, British Columbia, Canada
- Oncology pharmacist: Dr Sonia Amin Thomas, Georgia, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
touchIN CONVERSATION for touchNEUROLOGY
Listen to a migraine specialist and a patient advocate discuss the burden of migraine and the importance of shared decision making in meeting patient-oriented goals.The discussion is stimulated by questions posed by healthcare professionals involved in the management of migraine. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly.This medical education is provided by touchIME.For further information visit our website:www.touchneurology.com
touchIN CONVERSATION for touchNEUROLOGY
Listen to a world-renowned expert in Alzheimer’s disease, Professor George Grossberg, and an active Alzheimer’s caregiver advocate, Ms Susan Miller, discuss their insights and experiences on overcoming barriers to diagnosis and addressing symptomatic treatment needs through effective treatment choices and shared-management approaches.
The discussion is stimulated by real-world questions posed by healthcare professionals involved in the management of Alzheimer’s disease.
This touchPODCAST is for healthcare professionals only.
This activity is funded by an independent medical education grant from Corium Inc and is jointly provided by USF Health and touchIME.
For further information visit our website: https://www.touchneurology.com
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to Dr Leonard Bacharier, a paediatric asthma specialist, in conversation with Dr Dermot Ryan, a primary care respiratory specialist. They respond to questions submitted by the HCP audience and provide their expert insights on best practices and the latest developments in the diagnosis, treatment and long-term management of children with severe asthma.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://www.touchimmunologyime.org/improving-outcomes-in-severe-paediatric-asthma/
touchIN CONVERSATION for touchRESIPIRATORY
Listen to Dr Leonard Bacharier, a paediatric asthma specialist, in conversation with Dr Dermot Ryan, a primary care respiratory specialist. They respond to questions submitted by the HCP audience and provide their expert insights on best practices and the latest developments in the diagnosis, treatment and long-term management of children with severe asthma.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/improving-outcomes-in-severe-paediatric-asthma/
touchSATELLITE SYMPOSIUM for touchONCOLOGY
Listen to a satellite symposium presented by three experts in chronic myeloid leukaemia, Professor Susanne Saussele, the chair for the symposium, and Professors Valentín García Gutiérrez and Massimo Breccia.
The first session led by Professor Valentín García Gutiérrez focuses on the toxicities associated with TKIs used to treat CML and how these affect patient management.
The second session led by Professor Massimo Breccia discusses the unmet needs in patients with CML being treated in the third- or later-line setting and how new and emerging treatments may address these needs.
In the third session, Professor Susanne Saussele reviews the current treatment paradigm for CML, highlighting areas where new and emerging agents may have a role, and indicating therapeutic settings that remain challenging.
The symposium concludes with a discussion of treatment options for three challenging patient case studies.
This activity is funded by an unrestricted independent medical education grant from Novartis and is provided by touchIME.
For further information visit our website: www.touchoncology.com/education/tackling-unmet-treatment-needs-in-cml/
touchIN CONVERSATION for touchENDOCRINOLOGY
Listen to two specialists in autoimmune liver disease, Professor Gideon Hirschfield and Dr Palak Trivedi, discuss current best practice for the treatment of primary biliary cholangitis, the evolving therapeutic landscape of the disease and processes for personalizing the treatment and management.
The discussion is stimulated by questions posed by healthcare professionals involved in the management of primary biliary cholangitis.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Ipsen Biopharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to two specialists in autoimmune liver disease, Professor Gideon Hirschfield and Dr Palak Trivedi, discuss current best practice for the treatment of primary biliary cholangitis, the evolving therapeutic landscape of the disease and processes for personalizing the treatment and management.
The discussion is stimulated by questions posed by healthcare professionals involved in the management of primary biliary cholangitis.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Ipsen Biopharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the latest guidelines for identifying and treating patients with HER2+ colorectal cancer, as well as the efficacy and safety data for HER2-targeted agents and their impact on clinical practice.
The experts
- Dr Ian Chau, Royal Marsden Hospital, London, UK
- Dr Antonia Sepulveda, George Washington University, Washington, DC, USA
- Dr Silvia Marsoni, IFOM ETS, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. and Astellas Pharma Inc., and is jointly provided by USF Health and touchIME.
For further information please visit: XXX
touchCONGRESS for touchENDOCRINOLOGY
Listen to a menopause expert review key data from The North American Menopause Society Annual Meeting 2022 and the 18th World Congress on Menopause on pharmacological treatments for vasomotor symptoms associated with menopause. Menopause experts offer their views on the potential impact of these data on clinical practice during expert interviews.
The experts
- Prof. Steven Goldstein, NYU Grossman School of Medicine, New York City, NY, USA
- Dr Samuel Lederman, Women’s Care Florida, West Palm Beach, FL, USA
- Prof. JoAnn Pinkerton, University of Virginia Health System, Charlottesville, VA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Astellas and is jointly provided by USF Health and touchIME.
For further information visit: touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team, plus a caregiver for a patient with TSC, discuss emerging agents for the treatment of patients with TSC-associated seizures and the potential they hold for improving patient outcomes
The multidisciplinary team:
- Paediatric neurologist and epilepsy specialist: Prof. James Wheless, Tennessee, USA
- Epilepsy specialist: Prof. Katarzyna Kotulska, Warsaw, Poland
- Patient caregiver: Ms Lisa Moss, Maryland, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
Listen to key experts from a multidisciplinary team review the potential for approved and emerging treatments to prevent or delay the onset of seizures in patients with TSC
The multidisciplinary team:
- Epilepsy specialist: Prof. Katarzyna Kotulska, Warsaw, Poland
- Paediatric neurologist and epilepsy specialist: Prof. James Wheless, Tennessee, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
Listen to key experts from a multidisciplinary team, plus a caregiver for a patient with TSC, discuss the clinical burden of TSC-associated seizures, current treatment options and unmet needs for patients and caregivers
The multidisciplinary team
- Paediatric neurologist and epilepsy specialist: Prof. James Wheless, Tennessee, USA
- Epilepsy specialist: Prof. Katarzyna Kotulska, Warsaw, Poland
- Patient caregiver: Ms Lisa Moss, Maryland, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.For further information visit our website:
touchCONGRESS for touchONCOLOGY
Listen to three experts explore the latest data from the ESGO European Congress on Gynaecological Oncology 2022 on the use of PARP inhibitors in first-line maintenance therapy for advanced ovarian cancer.
The experts
- Prof. Jonathan Ledermann, UCL Cancer Institute, London, UK
- Dr David Tan, National University Cancer Institute, Singapore
- Dr Anna Tinker, BC Cancer, Vancouver, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from GlaxoSmithKline. This medical education is provided by touchIME.
For further information, visit our website: https://touchoncology.com/
touchIN CONVERSATION for touchINFECTIOUS DISEASES
Listen to Prof. Doreen Addrizzo-Harris in conversation with Dr Ashwin Basavaraj. They respond to questions submitted by the HCP audience and provide their expert insights on reducing diagnostic delays and the initiation of guideline-based treatment for patients with NTM-LD, setting individualized treatment goals, and optimizing outcomes.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchinfectiousdiseases.com
touchIN CONVERSATION for touchRESPIRATORY
Listen to Prof. Doreen Addrizzo-Harris in conversation with Dr Ashwin Basavaraj. They respond to questions submitted by the HCP audience and provide their expert insights on reducing diagnostic delays and the initiation of guideline-based treatment for patients with NTM-LD, setting individualized treatment goals, and optimizing outcomes.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchrespiratory.com
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team discuss the current treatment guidelines for stroke management and prevention in patients with T2D and the key data that support them
The multidisciplinary team
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss the risk factors for stroke in patients with T2D and its impact upon daily life
The multidisciplinary team
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Patient: Ms Hyvelle Ferguson-Davis, Florida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss the risk factors for stroke in patients with T2D and its impact upon daily life
The multidisciplinary team
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Patient: Ms Hyvelle Ferguson-Davis, Florida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss the current treatment guidelines for stroke management and prevention in patients with T2D and the key data that support them
The multidisciplinary team
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss how the MDT can effectively collaborate to improve stroke outcomes in patients with T2D in clinical practice
The multidisciplinary team
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
- Patient: Ms Hyvelle Ferguson-Davis, Florida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team, plus a patient with T2D who has survived a stroke, discuss how the MDT can effectively collaborate to improve stroke outcomes in patients with T2D in clinical practice
The multidisciplinary team
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
- Patient: Ms Hyvelle Ferguson-Davis, Florida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D
The multidisciplinary team
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D
The multidisciplinary team
- Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
- Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
- Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the clinical relevance of the immunogenicity of immune checkpoint inhibitors for the treatment of cancer, informed by experience in inflammatory diseases.
The experts:
Prof. Peter Galle, University of Mainz, Germany,
Dr Victor Moreno, START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain,
Dr Vibeke Strand, Stanford University School of Medicine, Palo Alto, CA, USA.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, and a patient with PNH, discuss the signs and symptoms of PNH and how these inform the clinical diagnosis.
The multidisciplinary team
- Primary care physician: Dr Will Evans, UK
- Haematologist: Professor Régis Peffault de Latour, France
- Patient: Ms Jess Ratcliffe, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit: touchONCOLOGY
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team explore the use of complement inhibitors for patients with PNH.
The multidisciplinary team
- Primary care physician: Dr Will Evans, UK
- Haematologist: Professor Régis Peffault de Latour, France
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit: touchONCOLOGY
touchMDT for touchONCOLOGY
Listen to a haematologist and a patient with PNH discuss the experience of living with PNH from a patient’s perspective.
The multidisciplinary team
- Haematologist: Professor Régis Peffault de Latour, France
- Patient: Ms. Jess Ratcliffe, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit: touchONCOLOGY
touchIN CONVERSATION for touchONCOLOGY
Listen to two chronic myeloid leukaemia experts, Prof. Simona Soverini and Dr Daniela Žáčková discuss the mechanisms of action and latest data for new and emerging treatment options for patients with chronic myeloid leukaemia after two prior lines of therapy, and how they might impact the management of chronic myeloid leukaemia. The discussion is guided by pre-canvassed questions from the chronic myeloid leukaemia clinical community.
This touchPODCAST is intended for non-UK and non-US HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis and is provided by touchIME.
For further information visit our website touchONCOLOGY
Video 1: Listen to key experts from a multidisciplinary team discuss the pathophysiology and comorbidities of non-CF bronchiectasis.
The multidisciplinary team
- Primary care physician: Professor Barbara Yawn, USA
- Pulmonologist: Professor James Chalmers, Scotland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.
For further information visit: touchRESPIRATORY
Video 3: Listen to key experts from a multidisciplinary team, and a patient, review the diagnostic tools for non-CF bronchiectasis.
The multidisciplinary team
- Primary care physician: Professor Barbara Yawn, USA
- Pulmonologist: Professor James Chalmers, Scotland
- Radiologist: Professor Mary Salvatore, USA
- Patient: Marta Almagro, Spain
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.
For further information visit: touchRESPIRATORY
Video 3: Listen to key experts from a multidisciplinary team, and a patient, review the diagnostic tools for non-CF bronchiectasis.
The multidisciplinary team
- Primary care physician: Professor Barbara Yawn, USA
- Pulmonologist: Professor James Chalmers, Scotland
- Radiologist: Professor Mary Salvatore, USA
- Patient: Marta Almagro, Spain
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.
For further information visit: touchINFECTIOUS DISEASES
Video 2: Listen to key experts from a multidisciplinary team, and a patient, explore the key signs and symptoms of non-CF bronchiectasis and how these inform the clinical diagnosis.
The multidisciplinary team
- Pulmonologist: Professor James Chalmers, Scotland
- Primary care physician: Professor Barbara Yawn, USA
- Patient: Marta Almagro, Spain
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.
For further information visit: touchINFECTIOUS DISEASES
Video 1: Listen to key experts from a multidisciplinary team discuss the pathophysiology and comorbidities of non-CF bronchiectasis.
The multidisciplinary team
- Primary care physician: Professor Barbara Yawn, USA
- Pulmonologist: Professor James Chalmers, Scotland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.
For further information visit: touchINFECTIOUS DISEASES
Video 2: Listen to key experts from a multidisciplinary team, and a patient, explore the key signs and symptoms of non-CF bronchiectasis and how these inform the clinical diagnosis.
The multidisciplinary team
- Pulmonologist: Professor James Chalmers, Scotland
- Primary care physician: Professor Barbara Yawn, USA
- Patient: Marta Almagro, Spain
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.
For further information visit: touchRESPIRATORY
touchIN CONVERSATION for touchCARDIO.
Listen to Prof. Kausik Ray in conversation with Dr Mahir Karakas. They respond to questions submitted by the HCP audience and provide their expert insights on how the latest guidelines and treatments can be applied to reduce ASCVD risk in patients with dyslipidemias.
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent educational grant from Novartis. The content was led by touchIME.
For further information visit our website:
https://touchendocrinologyime.org/in-conversation-guidelines-novel-therapies-emerging-options-for-managing-dyslipidemias-ASCVD-risk
Listen to Prof. Peter Rossing in conversation with Dr Eden Miller. They respond to questions submitted by the HCP audience and provide their expert insights on monitoring CKD progression, reducing the risk of cardiorenal outcomes, and applying the latest guidelines on CKD and T2D to daily practice.
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent educational grant from Bayer. The content was led by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/in-conversation-addressing-cardiorenal-outcomes-in-CKD-and-T2D
Listen to Prof. Peter Rossing in conversation with Dr Eden Miller. They respond to questions submitted by the HCP audience and provide their expert insights on monitoring CKD progression, reducing the risk of cardiorenal outcomes, and applying the latest guidelines on CKD and T2D to daily practice.
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent educational grant from Bayer. The content was led by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/in-conversation-addressing-cardiorenal-outcomes-in-CKD-and-T2D
touchEXPERT OPINIONS for touchONCOLOGY
Listen to two leading experts give their insights on the recommended workup for a timely and accurate diagnosis, as well as the evolving treatment landscape, and importance of individualizing therapy for patients with cold agglutinin disease.
The experts
- Dr Catherine M Broome, MedStar Georgetown University Hospital Washington DC, USA
- Dr Ilene Ceil Weitz, Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine Los Angeles, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion AstraZeneca Rare Disease and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/getting-personal-individualizing-therapy-for-cold-agglutinin-disease/
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of leading experts discuss the pathophysiology of cold agglutinin disease (CAD), the steps needed for an accurate diagnosis, and how emerging treatment options are changing the management of patients with primary CAD.
The experts
- Prof. Morie Gertz, Mayo Clinic, Rochester, Minnesota, USA
- Prof. Bernd Jilma, Medical University of Vienna, Austria
- Dr Shirley D'Sa, University College London Hospitals, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME.
For further information visit: touchIMMUNOLOGY
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the pathophysiology of cold agglutinin disease (CAD), the steps needed for an accurate diagnosis, and how emerging treatment options are changing the management of patients with primary CAD.
The experts
- Prof. Morie Gertz, Mayo Clinic, Rochester, Minnesota, USA,
- Prof. Bernd Jilma, Medical University of Vienna, Austria,
- Dr Shirley D'Sa, University College London Hospitals, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/understanding-the-immunopathogenesis-of-cad-what-are-the-implications-of-new-and-emerging-therapies
touchCONGRESS for touchONCOLOGY
Listen to urological cancer expert Prof. Axel Merseburger (Germany) review key data presented at ESMO 2022 exploring recent advances in immunotherapies and targeted treatments for patients with bladder cancer. He then offers his views on the potential impact of these data on clinical practice, alongside expert insights from Dr Bradley McGregor (USA) and Prof. Andrea Necchi (Italy).
OVERVIEW
Data Review with Prof. Merseburger (00:00)
Expert interviews with Prof. Merseburger, Dr McGregor and Prof. Necchi answering the questions below
INTERVIEW QUESTIONS
- Based on data recently presented at ESMO 2022, how do you think new and emerging immunotherapy agents and targeted treatments for patients with bladder cancer will impact the treatment landscape? (31:45)
- How can key learnings from ESMO 2022 be integrated into clinical practice when choosing between available regimens? (37:42)
- How is our understanding of the role of PD-L1 as a biomarker in bladder cancer evolving in light of recent data, and what are the possible implications for clinical practice? (44:35)
- What unmet needs remain surrounding biomarkers beyond PD-L1 in bladder cancer, and what are the prospects for biomarker-driven individualized treatment decisions in future? (51:14)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Seagen Inc. and Astellas Pharma Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/bladder-cancer-esmo2022-touchcongress/https://touchoncologyime.org/bladder-cancer-esmo2022-touchcongress/
touchMDT for touchNEUROLOGY
Listen to a patient advocate and person living with MS and two MS specialist neurologists discuss the importance of understanding the needs and preferences of patients at each treatment decision-making moment.
The multidisciplinary team
- Patient advocate/person living with MS: Ms Nele Handwerker, Germany
- Neurologist/MS specialist: Prof. Tjalf Ziemssen, Germany
- Neurologist/MS specialist: Prof. Tobias Derfuss, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchNEUROLOGY.com
touchMDT for touchNEUROLOGY
Listen to an imaging specialist and two neurologists specializing in MS care discuss the imaging modalities available to assess disease progression in MS.
The multidisciplinary team
- Imaging specialist: Dr Francesca Bagnato, USA
- Neurologist/MS specialist: Prof. Tjalf Ziemssen, Germany
- Neurologist/MS specialist: Prof. Tobias Derfuss, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchneurology.com/cme/integrating-practice-to-enhance-ms-patient-care/
touchMDT for touchNEUROLOGY
Listen to two neurologists specializing in MS care discuss the management of MS throughout the lifetime of patients and consider treatment switching strategies at key milestones (e.g. during the paediatric, childbearing and elderly years).
The experts
- Neurologist/MS specialist: Prof. Tjalf Ziemssen, Germany
- Neurologist/MS specialist: Prof. Tobias Derfuss, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchneurology.com/cme/integrating-practice-to-enhance-ms-patient-care/
touchIN CONVERSATION for touchONCOLOGY
Listen to two breast cancer experts, Prof. Peter Schmid and Dr Marleen Kok discuss the mechanisms of action and latest data for emerging treatment options and how they are changing the management of metastatic triple negative breast cancer (mTNBC). The discussion is guided by pre-canvassed questions from the breast cancer clinical community.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Gilead and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/evolving-treatment-landscape-in-mtnbc/
Video 4: Managing disease progression: Considerations for treatment selection and sequencing
Listen to leading specialists from the MDT discuss the role of monitoring in identifying disease progression, and review the current and emerging treatment options for a patient with a pancreatic NET.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/
Video 3: Supporting treatment adherence: What strategies are needed for safety management?
Listen to leading specialists from the MDT discuss the side effects associated with treatment in a patient with liver-dominant disease and the importance of addressing patient needs in ensuring adherence to treatment.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/
Video 2: Mapping an individualized treatment plan: What role does the MDT play?
Listen to leading specialists from the MDT discuss the importance of a coordinated approach to clinical decision making in a patient with a lung NET.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/
Video 1: Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?
Listen to leading specialists from the MDT discuss the diagnostic workup and challenges associated with diagnosing rare and unusual NETs.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/mdt-management-nets/
Video 4: Managing disease progression: Considerations for treatment selection and sequencing
Listen to leading specialists from the MDT discuss the role of monitoring in identifying disease progression, and review the current and emerging treatment options for a patient with a pancreatic NET.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/mdt-management-nets/
Video 3: Supporting treatment adherence: What strategies are needed for safety management?
Listen to leading specialists from the MDT discuss the side effects associated with treatment in a patient with liver-dominant disease and the importance of addressing patient needs in ensuring adherence to treatment.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/mdt-management-nets/
Video 2: Mapping an individualized treatment plan: What role does the MDT play?
Listen to leading specialists from the MDT discuss the importance of a coordinated approach to clinical decision making in a patient with a lung NET.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/mdt-management-nets/
Video 1: Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?
Listen to leading specialists from the MDT discuss the diagnostic workup and challenges associated with diagnosing rare and unusual NETs.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/mdt-management-nets/
Video 4: Managing disease progression: Considerations for treatment selection and sequencing
Listen to leading specialists from the MDT discuss the role of monitoring in identifying disease progression, and review the current and emerging treatment options for a patient with a pancreatic NET.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/
Video 3: Supporting treatment adherence: What strategies are needed for safety management?
Listen to leading specialists from the MDT discuss the side effects associated with treatment in a patient with liver-dominant disease and the importance of addressing patient needs in ensuring adherence to treatment.
The multidisciplinary team and patient
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Nurse specialist: Catherine Bouvier Ellis, UK
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/
Video 2: Mapping an individualized treatment plan: What role does the MDT play?
Listen to leading specialists from the MDT discuss the importance of a coordinated approach to clinical decision making in a patient with a lung NET.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/
Video 1: Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?
Listen to leading specialists from the MDT discuss the diagnostic workup and challenges associated with diagnosing rare and unusual NETs.
The multidisciplinary team
- Medical oncologist: Dr Diane Reidy-Lagunes, USA
- Nuclear medicine physician: Dr Thomas Hope, USA
- Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.
This medical education is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to two expert dermatologists, Dr Maryanne Senna and Dr Anna Waśkiel-Burnat, discuss current understanding of alopecia areata, including the burden associated with the disease, its pathophysiology, and the potential role of emerging therapies in improving patient outcomes.
The discussion is stimulated by questions posed by healthcare professionals involved in the management of alopecia areata.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This medical education is provided by touchIME.
For further information visit our website: www.touchimmunology.com
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three experts describe the role of immune dysregulation in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), and summarize the rationale and available data for emerging immune-based therapeutic strategies. In a short panel discussion, they consider the possible impact these therapies may have on future clinical practice.
The experts
- Prof. Dr. med. Uwe Platzbecker — University Hospital Leipzig, Leipzig, Germany
- Prof. Agnieszka Wierzbowska — Medical University of Łódź, Copernicus Memorial Hospital, Łódź, Poland
- Prof. Valeria Santini — University of Florence, Florence, Italy
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: touchONCOLOGY
touchEXPERT OPINIONS for touchRESPIRATORY
Listen to three experts in cytomegalovirus (CMV) to learn about the unmet needs of solid organ transplant recipients susceptible to CMV infection. Topics covered will include management challenges in solid organ transplant recipients with CMV, the evolving antiviral options for refractory and resistant CMV, and best practice for the management of refractory/resistant CMV in these patients.
The experts
- Dr Camille Kotton – Massachusetts General Hospital, Boston, MA, USA
- Dr Raymund Razonable – Mayo Clinic, Rochester, MN, USA
- Dr Genovefa Papanicolaou – Memorial Sloan Kettering Cancer Center, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Takeda. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/eo-on-cmv-in-solid-organ-transplant-recipients/
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES
Listen to three experts in cytomegalovirus (CMV) to learn about the unmet needs of solid organ transplant recipients susceptible to CMV infection. Topics covered will include management challenges in solid organ transplant recipients with CMV, the evolving antiviral options for refractory and resistant CMV, and best practice for the management of refractory/resistant CMV in these patients.
The experts
- Dr Camille Kotton – Massachusetts General Hospital, Boston, MA, USA
- Dr Raymund Razonable – Mayo Clinic, Rochester, MN, USA
- Dr Genovefa Papanicolaou – Memorial Sloan Kettering Cancer Center, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Takeda. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: URL
touchEXPERT OPINIONS for touchIMMUNOLOGY
Listen to three experts in eosinophilic oesophagitis (EoE) to learn about the aetiology, pathophysiology and clinical manifestations of EoE, as well as the practical aspects of its diagnosis and management in children and adults based on clinical case studies.
The experts
- Dr Stuart Carr – Snö Asthma and Allergy, Abu Dhabi, UAE
- Dr Mário Vieira – Hospital Pequeno Príncipe, Curitiba, PR, Brazil
- Prof. Arjan Bredenoord – Amsterdam University Medical Center, Amsterdam, Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchIMMUNOLOGY
touchEXPERT OPINIONS for touchRESPIRATORY
Listen to three experts in eosinophilic oesophagitis (EoE) to learn about the aetiology, pathophysiology and clinical manifestations of EoE, as well as the practical aspects of its diagnosis and management in children and adults based on clinical case studies.
The experts
- Dr Stuart Carr – Snö Asthma and Allergy, Abu Dhabi, UAE
- Dr Mário Vieira – Hospital Pequeno Príncipe, Curitiba, PR, Brazil
- Prof. Arjan Bredenoord – Amsterdam University Medical Center, Amsterdam, Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchRESPIRATORY
touchCONGRESS for touchONCOLOGY
Listen to Dr Esther Oliva (Italy) review key data presented at the EHA 2022 Hybrid Congress on recent developments in the treatment of higher-risk MDS and newly diagnosed AML; she offers her expert insights on their potential impact on future clinical practice, alongside those from Prof. Michael Heuser (Germany) and Dr Yishai Ofran (Israel).
OVERVIEW
- Data review with Dr Oliva (0:00)
- Expert interviews with Prof. Heuser, Dr Ofran and Dr Oliva, answering the questions below
INTERVIEW QUESTIONS
- Based on data presented at EHA 2022, which emerging treatments are most likely to impact future clinical practice for patients with HR-MDS? (30:08)
- What do the latest data presented at EHA 2022 tell us about the clinical relevance of TP53 mutation in HR-MDS and newly diagnosed AML? (35:47)
- To what extent will lower-intensity treatment regimens improve patient outcomes in newly diagnosed AML ineligible for intensive chemotherapy? Which of the emerging regimens do you think will be most important? (42:06)
- Based on the latest research presented at EHA 2022, which prognostic tools and biomarkers do you consider most promising to support treatment decisions in HR-MDS or newly diagnosed AML? (49:55)
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/MDS-AML-EHA2022-touchcongress/
Listen to a panel of leading lung cancer experts share their perspectives on recent advances in the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) and how they are changing clinical practice.
The experts
- Dr Marina Garassino - University of Chicago, Chicago, IL, USA
- Dr Louis Paz-Ares - Hospital Universitario 12 de Octubre, Complutense University and Ciberonc, Madrid, Spain
- DR Martin Edelman - Fox Chase Cancer Center, Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/ES-SCLC-first-line-treatment
touchTALKS for touchONCOLOGY
Listen to an esteemed lung cancer expert discuss KRAS mutations in solid tumours, particularly non-small cell lung cancer and colorectal cancer, and consider the role of direct KRAS-G12C inhibitors in targeting these mutations and potential strategies to overcome resistance.
The expert:
- Prof. Tony Mok, Chinese University of Hong Kong, Hong Kong
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/kras-g12c-inhibitors-for-solid-tumours/
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Cristina Suárez, a clinician in Spain with a specialist focus on genitourinary tumors, in conversation with Dr Toni Choueiri, a renal cell carcinoma (RCC) expert. They respond to questions submitted by the HCP audience and provide their expert insights on how emerging combination therapies in the first-line setting can improve outcomes for patients with advanced RCC.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Exelixis, Inc., and Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/in-conversation-improving-outcomes-advanced-rcc-role-of-emerging-combinations-first-line/
touchIN CONVERSATION for touchENDOCRINOLOGY
Listen to Dr Nadia Merchant in conversation with Dr Andrew Dauber. They respond to questions submitted by the HCP audience and provide their expert insights on the physiology of normal and abnormal bone growth, and the assessment and treatment of children with achondroplasia.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/in-conversation-paediatric-growth-patterns-and-their-impact-on-health-in-achondroplasia
touchTALKS for touchRESPIRATORY
Listen to an esteemed lung cancer expert discuss KRAS mutations in solid tumours, particularly non-small cell lung cancer and colorectal cancer, and consider the role of direct KRAS-G12C inhibitors in targeting these mutations and potential strategies to overcome resistance.
The expert:
- Prof. Tony Mok, Chinese University of Hong Kong, Hong Kong
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: https://www.touchrespiratory.com/education/kras-g12c-inhibitors-for-solid-tumours/
touchCONGRESS for touchONCOLOGY
Listen to Professor Giuseppe Saglio (Italy) cover key data presented at the EHA Hybrid Conference 2022 on the efficacy and safety of current and emerging treatments for CML, and how these may influence clinical practice, as well as expert insights and interpretation from Professor François-Xavier Mahon (France) and Professor Dietger Niederwieser (Germany).
Overview
- Data review with Professor Giuseppe Saglio (00:54)
- Expert interview with Professor Giuseppe Saglio, Professor François-Xavier Mahon and Professor Dietger Niederwieser (32:50)
Interview questions
- When considering the new 96-week data for asciminib from the ASCEMBL trial, how do you think these results will impact clinical practice? (35:00)
- In patients with absence of an optimal response on therapy, what can we learn from new data on switching TKIs? (41:00)
- What have we learnt about the clinical considerations for TKI discontinuation?(47:09)
- Extended use of TKIs is now commonplace; what safety aspects have we seen from long-term follow-up studies?(52:26)
- How should dose modifications be used for TKIs in clinical practice? (57:39)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Novartis Pharmaceuticals. This activity is provided by touchIME.
For further information visit our website: www.touchoncology.com
touchIN CONVERSATION for touchONCOLOGY
Listen to gynaecologic oncology specialists Prof. Nicoletta Colombo and Dr Natalia R Gómez-Hidalgo discuss three key topics relating to PARP inhibitors in the first-line maintenance setting for advanced ovarian cancer – rationale for use, which patients may particularly benefit, and key factors informing PARP inhibitor selection.
Discussion on these themes is based on questions posed by healthcare professionals involved in the care of patients with ovarian cancer.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This medical education is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/parp-inhibitors-maintenance-inconvo2022/
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.
The experts
Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA
Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK
Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: https://touchimmunologyime.org/
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.
The experts
Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA
Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK
Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: https://touchrespiratoryime.org/
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
- Prof. Gavin Giovannoni (Chair), Blizard Institute, Queen Mary University of London, UK
- Prof. Eva Havrdová, General Faculty Hospital, Charles University in Prague, Czech Republic
- Prof. Patrick Vermersch, Lille University Hospital, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer.
The experts
- Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil
- Prof. Dr. med. Nadia Harbeck - University of Munich (LMU), Munich, Germany
- Prof. Chiun-Sheng Huang - National Taiwan University Hospital, Taipei City, Taiwan
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Randy Broun, a community oncologist and haematologist, in conversation with Dr Faith Davies, a multiple myeloma expert. They respond to questions submitted by the HCP audience and provide their expert insights on how real-world evidence can guide the management of elderly and frail patients with multiple myeloma.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Takeda Pharmaceuticals USA Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchoncology.com
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan.
The experts
- Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil
- Prof. Joël Guigay - Cancer Center Antoine Lacassagne, Nice, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/
touchMDT for touchIMMUNOLOGY
Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon.
The multidisciplinary team
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
- Dietitian: Dr Isabel Skypala, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/
touchMDT for touchIMMUNOLOGY
Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction.
The multidisciplinary team
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Dietitian: Dr Isabel Skypala, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/
touchMDT for touchIMMUNOLOGY
Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis.
The multidisciplinary team
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/
touchMDT for touchRESPIRATORY
Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon.
The multidisciplinary team
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
- Dietitian: Dr Isabel Skypala, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/
touchMDT for touchRESPIRATORY
Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction.
The multidisciplinary team
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Dietitian: Dr Isabel Skypala, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/
touchMDT for touchRESPIRATORY
Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis.
The multidisciplinary team
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This medical education is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies.
The experts
- Dr Charles Daley – National Jewish Health and University of Colorado, Denver, CO, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Dr Anne O’Donnell – Georgetown University, Washington, DC, USAU
- Prof. Stefano Aliberti – Humanitas University, Humanitas Research Hospital, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/best-practice-for-management-of-non-cystic fibrosis-bronchiectasis/
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES
Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies.
The experts
- Dr Charles Daley – National Jewish Health and University of Colorado, Denver, CO, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Dr Anne O’Donnell – Georgetown University, Washington, DC, USA
- Prof. Stefano Aliberti – Humanitas University, Humanitas Research Hospital, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchinfectiousdiseasesime.org/best-practice-for-management-of-non-cystic fibrosis-bronchiectasis/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss strategies to maximize the quality of life of patients with chronic myeloid leukaemia in the later-line setting
The multidisciplinary team
- Pharmacist: Dr Bee Kim Tan, Malaysia
- Nurse specialist: Johan De Munter, Belgium
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team explore how to minimize toxicities while maximizing treatment benefit for patients with chronic myeloid leukaemia
The multidisciplinary team
- Nurse specialist: Johan De Munter, Belgium
- Haematologist: Prof. Dr med. Andreas Hochhaus, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the later-line treatment options for chronic myeloid leukaemia, including T315I mutation-positive disease
The multidisciplinary team
- Haematologist: Prof. Dr med. Andreas Hochhaus, Germany
- Pharmacist: Dr Bee Kim Tan, Malaysia
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, plus a patient advocate, consider real-life perspectives from patients with chronic myeloid leukaemia, and what HCPs can learn from them to improve outcomes
The multidisciplinary team
- Haematologist: Prof. Dr med. Andreas Hochhaus, Germany
- Patient advocate: Jelena Čugurović, Serbia
- Nurse specialist: Johan De Munter, Belgium
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/
touchMDT for touchONCOLOGY
Listen to a medical oncologist, a urologist and an oncology pharmacist discuss extending the benefit of PARP inhibitors through combinations for the treatment of advanced prostate cancer.
The multidisciplinary team
- Medical Oncologist: Dr Wassim Abida, USA
- Urologist: Professor Axel Merseburger, Germany
- Oncology Pharmacist: Dr Lisa Holle, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/
touchMDT for touchONCOLOGY
Listen to a urologist and a medical oncologist discuss key clinical trials investigating PARP inhibitor combinations for the treatment of advanced prostate cancer.
The multidisciplinary team
- Urologist: Professor Axel Merseburger, Germany
- Medical Oncologist: Dr Wassim Abida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/
touchMDT for touchONCOLOGY
Listen to an oncology pharmacist and a medical oncologist discuss the rationale for PARP inhibitors for the treatment of advanced prostate cancer.
The multidisciplinary team
- Oncology Pharmacist: Dr Lisa Holle, USA
- Medical Oncologist: Dr Wassim Abida, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/
touchIN CONVERSATION for touchRESPIRATORY
Listen to Professor Valerie Lund in conversation with Dr Sietze Reitsma. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://www.touchrespiratory.com/cme/minimizing-the-clinical-burden-of-chronic-rhinosinusitis-with-nasal-polyposis/
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to Professor Valerie Lund in conversation with Dr Sietze Reitsma. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://www.touchimmunology.com/cme/minimizing-the-clinical-burden-of-chronic-rhinosinusitis-with-nasal-polyposis/
touchPANEL DISCUSSION for touchNEUROLOGY
Listen as three experts in spinal muscular atrophy (SMA) discuss factors influencing treatment decision-making with approved SMA therapies using patient case studies.
The experts
- Prof. Eugenio Mercuri – Policlinico Universitario Agostino Gemelli, Rome, Italy
- Prof. Nathalie Goemans – UZ Leuven, Leuven, Belgium
- Prof. Dr. med. Tim Hagenacker – Essen University Hospital, Essen, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Biogen and Novartis Gene Therapies. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/selecting-disease-modifying-treatments-in-sma/
touchTALKS for touchNEUROLOGY
Listen to a leading expert in multiple sclerosis (MS) discuss how disease-modifying therapies are currently used in clinical practice for the optimal management of relapsing MS. Prof. Patricia K Coyle highlights the importance of reducing the burden of the often ‘invisible’ symptoms of MS, such as fatigue, on overall patient quality of life, and reviews the latest, potentially practice-changing developments, which could further improve patient outcomes through shared treatment decision making.
The expert
- Prof. Patricia K Coyle, MS Comprehensive Care Center, Stony Brook University Hospital, Stony Brook, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Janssen Pharmaceutica NV. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/dmts-in-rms/
touchCONGRESS for touchONCOLOGY
Listen to Prof. Isabelle Ray-Coquard (France) cover key data presented at SGO 2022 on PARP inhibitors as first-line maintenance therapy in ovarian cancer, and their implications for clinical practice, including expert insights and interpretation from Dr Antonio González-Martín (Spain) and Dr Sandro Pignata (Italy).
OVERVIEW
- Data review with Prof. Ray-Coquard (0:32)
- Expert interviews with Dr González-Martín, Dr Pignata and Prof. Ray-Coquard, answering the questions below
INTERVIEW QUESTIONS
-
- How have the clinical trial data regarding first-line maintenance with PARP inhibitors in patients with ovarian cancer changed our understanding of the efficacy of these treatments? (22:56)
- What have we learned about managing adverse events in patients with ovarian cancer receiving first-line maintenance with PARP inhibitors? (29:21)
- Based on the presentations at SGO 2022, are you likely to change how you personalize treatment by considering the patient’s molecular characteristics? (36:32)
- What can we learn from the real-world evidence for first-line maintenance with PARP inhibitors presented at SGO 2022? (43:15)
- How do you see the role and optimization of PARP inhibitors in the first-line maintenance treatment of advanced ovarian cancer evolving in the next 5 years? (49:39)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/parp-inhibitors-maintenance-sgo2022/
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team and a patient explore the role of GLP-1 RAs in the T2D management pathway, real-world factors affecting selection of a GLP-1 RA, and how GLP-1 RA therapy has influenced real-life patients in their glycemic and weight-loss goals
The multidisciplinary team and patient
- Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany
- Primary Care Physician: Dr Kevin Fernando, Berwick, UK
- Patient Advocate: Ms Kelly Ann Hardy, Margate, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team review the rationale for using GLP-1 as a therapeutic target in T2D and provide an overview of GLP-1 RA based therapies
The multidisciplinary team
- Primary Care Physician: Dr Kevin Fernando, Berwick, UK
- Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team and a patient explore the safety of GLP-1 RAs and the role of patient education in managing the side effects of these agents
The multidisciplinary team and patient
- Primary Care Physician: Dr Kevin Fernando, Berwick, UK
- Diabetes Nurse Specialist: Prof. Dr Şeyda Özcan, Istanbul, Turkey
- Patient Advocate: Ms Kelly Ann Hardy, Margate, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/
touchEXPERT OPINIONS for touchIMMUNOLOGY
Listen to leading experts discuss important considerations in the optimal management of patients with moderate-to-severe ulcerative colitis.
The experts
- Prof. Ailsa Hart – St Mark’s Hospital and Academic Institute, London, UK
- Dr Gil Y Melmed – Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- Prof. Brian G Feagan – University of Western Ontario, London, ON, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/improving-outcomes-uc
touchCONGRESS for touchRESPIRATORY
Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece).
Overview
- Data review with Dr Evan Dellon (00:55)
- Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05)
Interview questions
- How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40)
- How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23)
- What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12)
- Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18)
- What is your key takeaway from AAAAI 2022? (58:27)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://touchrespiratoryime.org/eoe-aaaai-2022/
touchCONGRESS for touchRESPIRATORY
Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece).
Overview
- Data review with Dr Evan Dellon (00:55)
- Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05)
Interview questions
- How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40)
- How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23)
- What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12)
- Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18)
- What is your key takeaway from AAAAI 2022? (58:27)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://touchimmunologyime.org/eoe-aaaai-2022/
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.
The experts:
- Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
- Dr Melinda Gooderham – SKiN Centre for Dermatology, Ontario, Canada
- Prof. David Khan – Southwestern Medical Center, University of Texas, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/
touchTALKS for touchRESPIRATORY
Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-diagnosis-treatment
touchTALKS for touchNEUROLOGY
Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease.
This touchPODCAST is for HCPs only
This activity is funded by an unrestricted independent medical education grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-diagnosis-treatment
touchMDT for touchINFECTIOUSDISEASES
Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss the important role of the multidisciplinary team in optimizing adherence to ART and health of PLHIV
The experts
- HIV Specialist: Dr Laura Waters, London, UK
- Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
- Advocate for PLHIV: Ms Susan Cole, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.
For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/
touchMDT for touchINFECTIOUSDISEASES
Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss factors impacting quality of life and adherence to ART in PLHIV.
The multidisciplinary team
- HIV Specialist: Dr Laura Waters, London, UK
- Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
- Advocate for PLHIV: Ms Susan Cole, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.
For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/
touchMDT for touchINFECTIOUSDISEASES
Listen to an HIV specialist, a specialist nurse and a clinical pharmacist discuss how they assess readiness to start ART and barriers to adherence.
The multidisciplinary team
- HIV Specialist: Dr Laura Waters, London, UK
- Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal
- Clinical Pharmacist: Ms Fiona Marra, Glasgow, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.
For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/
touchMDT for touchINFECTIOUSDISEASES
Listen to an HIV specialist and clinical pharmacist discuss PrEP and how factors affecting adherence may be overcome in different populations at risk of HIV infection.
The multidisciplinary team
- HIV Specialist: Dr Laura Waters, London, UK
- Clinical Pharmacist: Ms Fiona Marra, Glasgow, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.
For further information visit our website: https://touchinfectiousdiseases.com/education/mdt-hiv-art-adherence/
touchMDT for touchONCOLOGY
Listen to a gynaecologic oncologist, a clinical oncologist, and a radiation oncologist discuss the role of the MDT in implementing change to best practice care and the importance of keeping up to date with the latest clinical trial data.
The multidisciplinary team
- Gynaecologic oncologist: Prof. Bradley Monk, USA
- Clinical oncologist: Dr Mary McCormack, UK
- Radiation oncologist: Prof. Cyrus Chargari, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/optimizing-mdt-care-for-locally-advanced-cervical-cancer/
touchMDT for touchONCOLOGY
Listen to a clinical oncologist and a radiation oncologist discuss current treatment approaches for patients with locally advanced cervical cancer using a patient case to illustrate best practice with the standard of care; ongoing clinical trials are also highlighted.
The multidisciplinary team
- Clinical oncologist: Dr Mary McCormack, UK
- Radiation oncologist: Prof. Cyrus Chargari, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education request from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/optimizing-mdt-care-for-locally-advanced-cervical-cancer/
touchMDT for touchONCOLOGY
Listen to a gynaecologic oncologist and nurse practitioner discuss the prognostic risk factors for patients with LACC and how best to support patients throughout their treatment journey for optimal outcomes.
The multidisciplinary team
- Gynaecologic oncologist: Prof. Bradley Monk, USA
- Nurse practitioner: Ms Kathleen Smith, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education request from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/optimizing-mdt-care-for-locally-advanced-cervical-cancer/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, plus an EBC survivor, discuss the challenges around implementing SDM for patients with EBC, and how they may be overcome.
The multidisciplinary team
- Oncology surgeon: Prof. Dr Michael Gnant, Vienna, Austria
- EBC survivor: Ms Evelyn Ong, Singapore, Republic of Singapore
- Medical oncologist: Prof. Frances Boyle, Sydney, Australia
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the evidence and share real-world insights from their own clinical practice on the effects SDM has on patient outcomes in EBC.
The multidisciplinary team
- Nurse specialist: Prof. Dr Khatijah Lim Abdullah, Selangor, Malaysia
- Medical oncologist: Prof. Frances Boyle, Sydney, Australia
- Oncology surgeon: Prof. Dr Michael Gnant, Vienna, Austria
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, plus an EBC survivor, share their perspectives and own experiences with SDM in EBC, and explore key elements essential for its successful implementation.
The multidisciplinary team
- Medical oncologist: Prof. Frances Boyle, Sydney, Australia
- Nurse specialist: Prof. Dr Khatijah Lim Abdullah, Selangor, Malaysia
- EBC survivor: Ms Evelyn Ong, Singapore, Republic of Singapore
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/
touchMDT for touchONCOLOGY
Listen to a gynaecologic oncologist, a clinical oncologist, and a radiation oncologist discuss the role of the MDT in implementing change to best practice care and the importance of keeping up to date with the latest clinical trial data.
The multidisciplinary team
- Gynaecologic oncologist: Prof. Bradley Monk
- Clinical oncologist: Dr Mary McCormack, UK
- Radiation oncologist: Prof. Cyrus Chargari, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education request from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/
touchSATELLITE SYMPOSIUM for touchOPHTHALMOLOGY
Listen to three leading experts discuss diagnosis, treatment and care provision for patients with neuromyelitis optica spectrum disorder (NMOSD), with updates on the latest data for immunotherapy treatment options and guidance on how to support the holistic management of patients through multidisciplinary teams.
The experts
- Prof. Sean Pittock (Chair), Mayo Clinic, Rochester, MN, USA
- Dr Amy Kunchok, Cleveland Clinic, Cleveland, OH, USA
- Prof. Dean Wingerchuk, Mayo Clinic, Phoenix and Scottsdale, AZ, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/nmosd-diagnosis-management/
touchSATELLITE SYMPOSIUM for touchNEUROLOGY
Listen to three leading experts discuss diagnosis, treatment and care provision for patients with neuromyelitis optica spectrum disorder (NMOSD), with updates on the latest data for immunotherapy treatment options and guidance on how to support the holistic management of patients through multidisciplinary teams.
The Experts:
- Prof. Sean Pittock (Chair), Mayo Clinic, Rochester, MN, USA
- Dr Amy Kunchok, Cleveland Clinic, Cleveland, OH, USA
- Prof. Dean Wingerchuk, Mayo Clinic, Phoenix and Scottsdale, AZ, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurology.com/cme/nmosd-diagnosis-management/
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss established therapies for HFrEF and key efficacy and safety considerations for new and emerging therapies
The multidisciplinary team
- Primary care physician: Prof. Ahmet Fuat, Darlington, UK
- Cardiologist: Dr Akshay Desai, Boston, USA
- Patient: Ms Sarah Worsnop, Hull, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss the role of the multidisciplinary team in managing patients with HF
The multidisciplinary team
- Cardiologist: Dr Akshay Desai, Boston, USA
- Primary care physician: Prof. Ahmet Fuat, Darlington, UK
- Cardiology nurse specialist: Dr Carol Wade, Baltimore, USA
- Patient: Ms Sarah Worsnop, Hull, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team discuss latest guideline recommendations for HFrEF therapies and how new and emerging therapies may be incorporated into clinical practice, now and in the future
The multidisciplinary team
- Cardiology nurse specialist: Dr Carol Wade, Baltimore, USA
- Cardiologist: Dr Akshay Desai, Boston, USA
- Primary care physician: Prof. Ahmet Fuat, Darlington, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//
touchMDT for touchIMMUNOLOGY
Listen in as a dermatologist, a dermatopathologist, a radiation oncologist and a head and neck surgeon discuss the role of the multidisciplinary team in the care of patients with CSCC and how effective collaboration can improve outcomes for these patients.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
touchMDT for touchIMMUNOLOGY
Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.
The multidisciplinary team
- Dermato-oncologist: Dr Joël Claveau, Canada
- Dermatologist: Prof. Caroline Robert, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
touchMDT for touchIMMUNOLOGY
Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.
The multidisciplinary team
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
touchMDT for touchIMMUNOLOGY
Listen to a dermatologist and a dermatopathologist discuss the key recommendations for the diagnostic workup of patients with suspected CSCC, and consider how to accurately assess prognostic factors while identifying the key stakeholders involved in this crucial stage in the patient’s journey.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management
touchMDT for touchONCOLOGY
Listen in as a dermatologist, a dermatopathologist, a radiation oncologist and a head and neck surgeon discuss the role of the multidisciplinary team in the care of patients with CSCC and how effective collaboration can improve outcomes for these patients.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management
touchMDT for touchONCOLOGY
Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.
The multidisciplinary team
- Dermato-oncologist: Dr Joël Claveau, Canada
- Dermatologist: Prof. Caroline Robert, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management
touchMDT for touchONCOLOGY
Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.
The multidisciplinary team
- Radiation oncologist: Dr Agata Rembielak, UK
- Head and neck surgeon: Prof. Francesco Bussu, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management
touchMDT for touchONCOLOGY
Listen to a dermatologist and a dermatopathologist discuss the key recommendations for the diagnostic workup of patients with suspected CSCC, and consider how to accurately assess prognostic factors while identifying the key stakeholders involved in this crucial stage in the patient’s journey.
The multidisciplinary team
- Dermatologist: Prof. Caroline Robert, France
- Dermatopathologist: Dr Klaus Busam, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management
touchMDT for touchNEUROLOGY
Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
- Patient: Mr Jim Willison, Sheffield, OH, USA
- Physical Therapist: Dr Lisa Fukuzato, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
touchMDT for touchNEUROLOGY
Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
touchMDT for touchNEUROLOGY
Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Neurologist: Dr James Wymer, Gainesville, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
touchMDT for touchRESPIRATORY
Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
- Patient: Mr Jim Willison, Sheffield, OH, USA
- Physical Therapist: Dr Lisa Fukuzato, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/
touchMDT for touchRESPIRATORY
Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/
touchMDT for touchNEUROLOGY
Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Neurologist: Dr James Wymer, Gainesville, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies/?_ga=2.29473663.1151443503.1654521477-1202917360.1651662103
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies//?_ga=2.65262702.1175448380.1654530922-407959475.1653925964
touchMDT for touchNEUROLOGY
Listen to experts with multidisciplinary perspectives share their expert insights on the impact of cognitive dysfunction in relapsing MS, and how to best assess and manage the associated cognitive symptoms.
The multidisciplinary team
- Neurologist/MS specialist: Prof. Mark Freedman, Canada
- Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
- Neuropsychologist: Prof. Dawn Langdon, UK
- Advanced practice clinician: Ms Amy Perrin Ross, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms
touchMDT for touchNEUROLOGY
Listen to experts with multidisciplinary perspectives discuss the current treatment landscape for relapsing MS and how oral DMTs can improve patient outcomes.
The multidisciplinary team
- Neurologist/MS specialist: Prof. Mark Freedman, Canada
- Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
- Advanced practice clinician: Ms Amy Perrin Ross, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms
touchMDT for touchNEUROLOGY
Listen to experts with multidisciplinary perspectives, discuss the importance of early diagnosis of relapsing MS for improved long-term patient outcomes.
The multidisciplinary team
- Neurologist/MS specialist: Prof. Mark Freedman, Canada
- Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team and a patient discuss the benefits of early treatment intensification and weight loss for patients with T2D and obesity as well as the importance of effective patient education strategies.
The multidisciplinary team and patient
- Diabetes care & education specialist: Ms Jennifer Okemah, Kirkland, WA
- Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
- Patient: Ms Brittany Jones, Atlanta, GA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team and a patient explore the use of GLP-1 RA therapy to treat T2D and obesity, including observations from a patient’s perspective, and consider the evidence for incretin-based dual agonists in development
The multidisciplinary team and patient
- Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
- Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA
- Patient: Ms Brittany Jones, Atlanta, GA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/touchENDOCRINOLOGY
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team discuss the role of incretin hormones in healthy individuals and in those with T2D and share insights from the latest research in this field
The multidisciplinary team
- Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA
- Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.
For further information visit: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies.
The experts
- Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
- Dr Jean-Phillippe Metges, Brest University Hospital, Brest, France
- Dr Radka Obermannova, Masaryk Memorial Cancer Institute Brno, Czech Republic
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from from Novartis. This activity is provided by touchIME.
For further information visit our website: https://touchoncologyime.org/targeting-pathobio-of-ESCC-and-emerging-impact-of-IO
touchTALKS for touchONCOLOLOGY
Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)
The expert
- Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK
OVERVIEW
Part 1: Insights from 2021 (0:00) Part 2: Insights from ASCO and ESMO GI 2022 (13:29) Part 3: Insights from ESMO Congress 2022 (to follow) Part 4: Insights from 2022 – a round up (to follow)
This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: www.touchoncology.com
Listen to a genitourinary cancer expert outline the use of antibody–drug conjugates in the treatment of urothelial carcinoma, including their place in current treatment guidelines, clinical trial data and the management of possible adverse events.
The expert
- Dr Cora Sternberg, Weill Cornell Medicine, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Gilead Sciences and Seagen. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/antibody-drug-conjugates-in-urothelial-carcinoma/
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma.
The multidisciplinary team
- Pulmonologist: Professor Alberto Papi, Italy
- Allergist: Professor Ioana Agache, Romania
- Primary care physician: Professor Barbara Yawn, USA
- Patient: Ms JoJo O’Neal, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families.
The multidisciplinary team
- Primary care physician: Professor Barbara Yawn, USA
- Allergist: Professor Ioana Agache, Romania
- Patient: Ms JoJo O’Neal, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.
The multidisciplinary team
- Allergist: Professor Ioana Agache, Romania
- Primary care physician: Professor Barbara Yawn, USA
- Pulmonologist: Professor Alberto Papi, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families.
The multidisciplinary team
- Primary care physician: Professor Barbara Yawn, USA
- Allergist: Professor Ioana Agache, Romania
- Patient: Ms JoJo O’Neal, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.
The multidisciplinary team
- Allergist: Professor Ioana Agache, Romania
- Primary care physician: Professor Barbara Yawn, USA
- Pulmonologist: Professor Alberto Papi, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//
touchCONGRESS for touchONCOLOGY
Listen to Prof. Pierre Fenaux (France) review key data presented at ASH 2021 on emerging treatments for patients with higher-risk MDS and newly diagnosed AML and offer his insights on their potential impact on future clinical practice, alongside those from Dr Esther Oliva (Italy) and Prof. Andrew Wei (Australia).
OVERVIEW
- Data review with Prof. Fenaux (0:00)
- Expert interviews with Prof. Fenaux, Dr Oliva and Prof. Wei, answering the questions below
INTERVIEW QUESTIONS
- What have we learned about targeting specific mutations in MDS and how will this impact the treatment landscape in the future? (30:30)
- Based on presentations at ASH 2021, what other emerging treatments for higher-risk MDS are likely to influence clinical practice? (36:13)
- What have we learned about targeting specific mutations in patients with newly diagnosed AML not eligible for intensive chemotherapy, and how will this impact the treatment landscape in the future? (43:15)
- Based on presentations at ASH 2021, what other emerging treatments for patients with newly diagnosed AML unfit for intensive chemotherapy are likely to influence clinical practice? (50:06)
- What do presentations at ASH 2021 tell us about treatment personalization for patients with higher-risk MDS and newly diagnosed AML unfit for intensive chemotherapy? (55:13)
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mds-aml-ash-2021/
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three experts as they explore key clinical considerations when using immune checkpoint inhibitors to treat recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). The discussion includes the current role of immune checkpoint inhibitors, factors that may inform treatment decisions and approaches for managing side effects associated with immune checkpoint inhibitors.
The experts
- Prof. Kevin Harrington – The Institute of Cancer Research, London, UK
- Prof. Barbara Burtness – Yale Cancer Center, New Haven, CT, USA
- Prof. Jean-Pascal Machiels – Department of Medical Oncology, Cliniques Universitaire St-Luc, Brussels, Belgium
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/immunotherapy-rmhnscc-practical-considerations/
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts consider the current treatment options and unmet needs for patients with HPV-associated cancers, the link between HPV and TGF-β, and how this is driving the development of new treatments.
The experts
- Dr Judith Michels, Institut Gustave Roussy, Villejuif, France
- Dr Andrew Sikora, MD Anderson Cancer Center, Houston, TX, USA
- Dr Krishnansu Tewari, University of California, Irvine, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from GSK and Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/hpv-associated-cancers/?_ga=2.151091262.621073815.1642410762-2024672127.1626340027
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma.
The multidisciplinary team
- Pulmonologist: Professor Alberto Papi, Italy
- Allergist: Professor Ioana Agache, Romania
- Primary care physician: Professor Barbara Yawn, USA
- Patient: Ms JoJo O’Neal, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity jointly provided by USF Health and touchIME.
For further information visit: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions.
The experts
- Prof. Karim Fizazi - Gustave Roussy, Villejuif, France
- Dr Sandy Srinivas - Stanford University, Stanford, CA, USA
- Prof. Johann de Bono - The Institute of Cancer Research, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/icis-prostate-cancer/
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies.
The experts
- Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
- Dr Jean-Phillipe Metges, University Hospital of Brest, Brest, France
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: https://touchoncologyime.org/targeting-pathobio-of-ESCC-and-emerging-impact-of-IO
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma.
The experts
- Dr Katharine Woessner, Scripps Clinic Medical Group, San Diego, CA, USA
- Prof. Louis-Philippe Boulet, Laval University, Quebec City, Canada
- Prof. Arnaud Bourdin, Arnaud de Villeneuve Hospital, Montpellier, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/endotypes-for-treatment-selection-in-severe-T2-asthma/
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma.
The experts
- Dr Katharine Woessner, Scripps Clinic Medical Group, San Diego, CA, USA
- Prof. Louis-Philippe Boulet, Laval University, Quebec City, Canada
- Prof. Arnaud Bourdin, Arnaud de Villeneuve Hospital, Montpellier, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/endotypes-for-treatment-selection-in-severe-T2-asthma/